JPWO2021226135A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021226135A5 JPWO2021226135A5 JP2022567488A JP2022567488A JPWO2021226135A5 JP WO2021226135 A5 JPWO2021226135 A5 JP WO2021226135A5 JP 2022567488 A JP2022567488 A JP 2022567488A JP 2022567488 A JP2022567488 A JP 2022567488A JP WO2021226135 A5 JPWO2021226135 A5 JP WO2021226135A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrimidin
- chloro
- fluorophenyl
- morpholinyl
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims description 146
- -1 -CH 2 CF 3 Chemical group 0.000 claims description 82
- 150000003839 salts Chemical class 0.000 claims description 67
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 17
- 125000000217 alkyl group Chemical group 0.000 claims description 16
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims description 14
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 14
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 10
- 239000008194 pharmaceutical composition Substances 0.000 claims description 9
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims description 8
- 229910052799 carbon Inorganic materials 0.000 claims description 8
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 8
- 229910052736 halogen Inorganic materials 0.000 claims description 8
- 150000002367 halogens Chemical group 0.000 claims description 8
- 125000001072 heteroaryl group Chemical group 0.000 claims description 8
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 8
- 125000006704 (C5-C6) cycloalkyl group Chemical group 0.000 claims description 6
- 125000006163 5-membered heteroaryl group Chemical group 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- 125000006413 ring segment Chemical group 0.000 claims description 6
- 125000001424 substituent group Chemical group 0.000 claims description 6
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 6
- 125000006583 (C1-C3) haloalkyl group Chemical group 0.000 claims description 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 4
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims description 4
- 208000024827 Alzheimer disease Diseases 0.000 claims description 4
- 201000011240 Frontotemporal dementia Diseases 0.000 claims description 4
- 208000021320 Nasu-Hakola disease Diseases 0.000 claims description 4
- 208000018737 Parkinson disease Diseases 0.000 claims description 4
- 208000024777 Prion disease Diseases 0.000 claims description 4
- 208000006011 Stroke Diseases 0.000 claims description 4
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 4
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 claims description 4
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 201000006417 multiple sclerosis Diseases 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 208000031334 polycystic lipomembranous osteodysplasia with sclerosing leukoencephaly Diseases 0.000 claims description 4
- 230000002265 prevention Effects 0.000 claims description 4
- 125000004076 pyridyl group Chemical group 0.000 claims description 4
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 4
- RADMRAMXLLLVGG-UHFFFAOYSA-N 1h-pyrido[4,3-d]pyrimidin-4-one Chemical compound C1=NC=C2C(=O)N=CNC2=C1 RADMRAMXLLLVGG-UHFFFAOYSA-N 0.000 claims description 3
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 2
- 125000004737 (C1-C6) haloalkoxy group Chemical group 0.000 claims description 2
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 claims description 2
- 125000004504 1,2,4-oxadiazolyl group Chemical group 0.000 claims description 2
- 125000001781 1,3,4-oxadiazolyl group Chemical group 0.000 claims description 2
- 125000006164 6-membered heteroaryl group Chemical group 0.000 claims description 2
- LAHGUIXDVLULPS-XMMPIXPASA-N CC(C)(C)OC(N(C1)CC1N1N=CC([C@@H](C2)OCCN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)=C1)=O Chemical compound CC(C)(C)OC(N(C1)CC1N1N=CC([C@@H](C2)OCCN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)=C1)=O LAHGUIXDVLULPS-XMMPIXPASA-N 0.000 claims description 2
- YGXJCOFVYSDAHO-OAQYLSRUSA-N CC(C)N1N=CC([C@@H](C2)OCCN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)=C1 Chemical compound CC(C)N1N=CC([C@@H](C2)OCCN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)=C1 YGXJCOFVYSDAHO-OAQYLSRUSA-N 0.000 claims description 2
- MZCLVUVJXAOVIA-UHFFFAOYSA-N CC(C1)(C2=CN(C)N=C2)OCCN1C(N=C1C(C=CC(Cl)=C2)=C2F)=CC(N=C(C)N2C)=C1C2=O Chemical compound CC(C1)(C2=CN(C)N=C2)OCCN1C(N=C1C(C=CC(Cl)=C2)=C2F)=CC(N=C(C)N2C)=C1C2=O MZCLVUVJXAOVIA-UHFFFAOYSA-N 0.000 claims description 2
- MLEILQWULATXIG-HXUWFJFHSA-N CC(C=C1)=CC(F)=C1C1=NC(N2C[C@H](C3=CN(C)N=C3)OCC2)=CC(N=C(C)N2C)=C1C2=O Chemical compound CC(C=C1)=CC(F)=C1C1=NC(N2C[C@H](C3=CN(C)N=C3)OCC2)=CC(N=C(C)N2C)=C1C2=O MLEILQWULATXIG-HXUWFJFHSA-N 0.000 claims description 2
- CXHFQZFPGYELIF-GOSISDBHSA-N CC(N1)=NC(C=C(N2C[C@H](C3=CN(C)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1)=NC(C=C(N2C[C@H](C3=CN(C)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O CXHFQZFPGYELIF-GOSISDBHSA-N 0.000 claims description 2
- JACVVMVPNCUMJA-UHFFFAOYSA-N CC(N1C)=NC(C=C(C2=CC(C3=CN(C)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(C2=CC(C3=CN(C)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O JACVVMVPNCUMJA-UHFFFAOYSA-N 0.000 claims description 2
- QTKRPXYIRLFZRQ-UHFFFAOYSA-N CC(N1C)=NC(C=C(N(CC2)CC2C(F)(F)F)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N(CC2)CC2C(F)(F)F)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O QTKRPXYIRLFZRQ-UHFFFAOYSA-N 0.000 claims description 2
- NTUVZSVXRMJAFX-UHFFFAOYSA-N CC(N1C)=NC(C=C(N(CC2)CC2C(F)F)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N(CC2)CC2C(F)F)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O NTUVZSVXRMJAFX-UHFFFAOYSA-N 0.000 claims description 2
- NPONVFZWCZQHJY-UHFFFAOYSA-N CC(N1C)=NC(C=C(N(CC2)CC2C2=CC=CN=C2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N(CC2)CC2C2=CC=CN=C2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O NPONVFZWCZQHJY-UHFFFAOYSA-N 0.000 claims description 2
- KHIBYUKKBKNLON-UHFFFAOYSA-N CC(N1C)=NC(C=C(N(CC2)CC3=C2C=NN3C)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N(CC2)CC3=C2C=NN3C)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O KHIBYUKKBKNLON-UHFFFAOYSA-N 0.000 claims description 2
- OVPZKBKJCLPWQF-UHFFFAOYSA-N CC(N1C)=NC(C=C(N(CC2)CC3=C2N=CN=C3OC)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N(CC2)CC3=C2N=CN=C3OC)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O OVPZKBKJCLPWQF-UHFFFAOYSA-N 0.000 claims description 2
- KDXABPIORINFKD-QGZVFWFLSA-N CC(N1C)=NC(C=C(N(CCC2(F)F)C[C@@H]2C2=CN(C)N=C2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N(CCC2(F)F)C[C@@H]2C2=CN(C)N=C2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O KDXABPIORINFKD-QGZVFWFLSA-N 0.000 claims description 2
- KDXABPIORINFKD-KRWDZBQOSA-N CC(N1C)=NC(C=C(N(CCC2(F)F)C[C@H]2C2=CN(C)N=C2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N(CCC2(F)F)C[C@H]2C2=CN(C)N=C2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O KDXABPIORINFKD-KRWDZBQOSA-N 0.000 claims description 2
- RQDYFABHDBBADE-UHFFFAOYSA-N CC(N1C)=NC(C=C(N(CCC2)CC2C(C2)CNC2=O)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N(CCC2)CC2C(C2)CNC2=O)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O RQDYFABHDBBADE-UHFFFAOYSA-N 0.000 claims description 2
- LZFPOMOBQPFPFL-UHFFFAOYSA-N CC(N1C)=NC(C=C(N(CCC2)CC2C2=CN=CO2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N(CCC2)CC2C2=CN=CO2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O LZFPOMOBQPFPFL-UHFFFAOYSA-N 0.000 claims description 2
- ZMDFKOUHBZVSLV-UHFFFAOYSA-N CC(N1C)=NC(C=C(N(CCC2)CC2N(C)C)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N(CCC2)CC2N(C)C)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O ZMDFKOUHBZVSLV-UHFFFAOYSA-N 0.000 claims description 2
- XEXFKLKWRXSHEZ-UHFFFAOYSA-N CC(N1C)=NC(C=C(N(CCC2)CC2N2CCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N(CCC2)CC2N2CCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O XEXFKLKWRXSHEZ-UHFFFAOYSA-N 0.000 claims description 2
- JFOOFAJCKKWLTK-QGZVFWFLSA-N CC(N1C)=NC(C=C(N(CCC2)C[C@@H]2C2=CC=NC=C2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N(CCC2)C[C@@H]2C2=CC=NC=C2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O JFOOFAJCKKWLTK-QGZVFWFLSA-N 0.000 claims description 2
- MWBMJQJWIZHCBF-CQSZACIVSA-N CC(N1C)=NC(C=C(N(CCC2)C[C@@H]2C2=CNN=C2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N(CCC2)C[C@@H]2C2=CNN=C2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O MWBMJQJWIZHCBF-CQSZACIVSA-N 0.000 claims description 2
- JFOOFAJCKKWLTK-KRWDZBQOSA-N CC(N1C)=NC(C=C(N(CCC2)C[C@H]2C2=CC=NC=C2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N(CCC2)C[C@H]2C2=CC=NC=C2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O JFOOFAJCKKWLTK-KRWDZBQOSA-N 0.000 claims description 2
- GJKYJWHXHAIEKU-HNNXBMFYSA-N CC(N1C)=NC(C=C(N(CCC2)C[C@H]2C2=CN(C)N=C2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N(CCC2)C[C@H]2C2=CN(C)N=C2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O GJKYJWHXHAIEKU-HNNXBMFYSA-N 0.000 claims description 2
- MWBMJQJWIZHCBF-AWEZNQCLSA-N CC(N1C)=NC(C=C(N(CCC2)C[C@H]2C2=CNN=C2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N(CCC2)C[C@H]2C2=CNN=C2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O MWBMJQJWIZHCBF-AWEZNQCLSA-N 0.000 claims description 2
- TZKJCPVWUGNPPW-UHFFFAOYSA-N CC(N1C)=NC(C=C(N(CCC2=CC=N3)CC2=C3Cl)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N(CCC2=CC=N3)CC2=C3Cl)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O TZKJCPVWUGNPPW-UHFFFAOYSA-N 0.000 claims description 2
- OWTZSDNCVXSPRO-UHFFFAOYSA-N CC(N1C)=NC(C=C(N2CC(C(C=C3)=CC=C3C#N)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2CC(C(C=C3)=CC=C3C#N)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O OWTZSDNCVXSPRO-UHFFFAOYSA-N 0.000 claims description 2
- RCXFHDUIDJDNGM-UHFFFAOYSA-N CC(N1C)=NC(C=C(N2CC(C3=CC(C(F)(F)F)=NC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2CC(C3=CC(C(F)(F)F)=NC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O RCXFHDUIDJDNGM-UHFFFAOYSA-N 0.000 claims description 2
- HEFUFVJEKGFWAL-UHFFFAOYSA-N CC(N1C)=NC(C=C(N2CC(C3=CC(F)=CN=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2CC(C3=CC(F)=CN=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O HEFUFVJEKGFWAL-UHFFFAOYSA-N 0.000 claims description 2
- DHOWSJAIGWVEPT-UHFFFAOYSA-N CC(N1C)=NC(C=C(N2CC(C3=CC=NN3C)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2CC(C3=CC=NN3C)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O DHOWSJAIGWVEPT-UHFFFAOYSA-N 0.000 claims description 2
- BGMCDTFJCOETNF-UHFFFAOYSA-N CC(N1C)=NC(C=C(N2CC(C3=CN=CN=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2CC(C3=CN=CN=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O BGMCDTFJCOETNF-UHFFFAOYSA-N 0.000 claims description 2
- RFBCCJHAQKOFCQ-UHFFFAOYSA-N CC(N1C)=NC(C=C(N2CC(C3=NC(C)=NC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2CC(C3=NC(C)=NC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O RFBCCJHAQKOFCQ-UHFFFAOYSA-N 0.000 claims description 2
- WVJLMJGGNGALSK-UHFFFAOYSA-N CC(N1C)=NC(C=C(N2CC(C3=NOC(C4=CC=CC=C4)=N3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2CC(C3=NOC(C4=CC=CC=C4)=N3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O WVJLMJGGNGALSK-UHFFFAOYSA-N 0.000 claims description 2
- RIYOXCNFDZQDBK-UHFFFAOYSA-N CC(N1C)=NC(C=C(N2CC(CC(F)(F)F)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2CC(CC(F)(F)F)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O RIYOXCNFDZQDBK-UHFFFAOYSA-N 0.000 claims description 2
- LRYVKAZBSIIHFU-NRFANRHFSA-N CC(N1C)=NC(C=C(N2C[C@@H](C(C=C3)=CC=C3Cl)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@@H](C(C=C3)=CC=C3Cl)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O LRYVKAZBSIIHFU-NRFANRHFSA-N 0.000 claims description 2
- RIUSFMUFAQAUGB-QFIPXVFZSA-N CC(N1C)=NC(C=C(N2C[C@@H](C(C=C3)=CC=C3OC)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@@H](C(C=C3)=CC=C3OC)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O RIUSFMUFAQAUGB-QFIPXVFZSA-N 0.000 claims description 2
- MRYZTVMKWPRFJW-NRFANRHFSA-N CC(N1C)=NC(C=C(N2C[C@@H](C3=CC(C(F)(F)F)=CC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@@H](C3=CC(C(F)(F)F)=CC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O MRYZTVMKWPRFJW-NRFANRHFSA-N 0.000 claims description 2
- UNPQXTOPIFSZHH-IBGZPJMESA-N CC(N1C)=NC(C=C(N2C[C@@H](C3=CC(Cl)=NC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@@H](C3=CC(Cl)=NC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O UNPQXTOPIFSZHH-IBGZPJMESA-N 0.000 claims description 2
- KWEFMKRWCSRYEB-NRFANRHFSA-N CC(N1C)=NC(C=C(N2C[C@@H](C3=CC(OC(F)(F)F)=CC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@@H](C3=CC(OC(F)(F)F)=CC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O KWEFMKRWCSRYEB-NRFANRHFSA-N 0.000 claims description 2
- YSDOJRNALAXGEP-QFIPXVFZSA-N CC(N1C)=NC(C=C(N2C[C@@H](C3=CC(OC)=CC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@@H](C3=CC(OC)=CC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O YSDOJRNALAXGEP-QFIPXVFZSA-N 0.000 claims description 2
- XMRFVSIYXMRJJY-FQEVSTJZSA-N CC(N1C)=NC(C=C(N2C[C@@H](C3=CC(OC)=NC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@@H](C3=CC(OC)=NC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O XMRFVSIYXMRJJY-FQEVSTJZSA-N 0.000 claims description 2
- PAOBOWAPYZTHSE-FQEVSTJZSA-N CC(N1C)=NC(C=C(N2C[C@@H](C3=CC(OCC(F)(F)F)=NC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@@H](C3=CC(OCC(F)(F)F)=NC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O PAOBOWAPYZTHSE-FQEVSTJZSA-N 0.000 claims description 2
- CNGXBYKVEIZZRH-FQEVSTJZSA-N CC(N1C)=NC(C=C(N2C[C@@H](C3=CC=CN=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@@H](C3=CC=CN=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O CNGXBYKVEIZZRH-FQEVSTJZSA-N 0.000 claims description 2
- NKVNWTMJZKRBPI-FQEVSTJZSA-N CC(N1C)=NC(C=C(N2C[C@@H](C3=CC=NC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@@H](C3=CC=NC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O NKVNWTMJZKRBPI-FQEVSTJZSA-N 0.000 claims description 2
- RNRBOSQPTFKPOY-IBGZPJMESA-N CC(N1C)=NC(C=C(N2C[C@@H](C3=CN(C)N=C3)OCC2)N=C2C(C=C3)=CC=C3Cl)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@@H](C3=CN(C)N=C3)OCC2)N=C2C(C=C3)=CC=C3Cl)=C2C1=O RNRBOSQPTFKPOY-IBGZPJMESA-N 0.000 claims description 2
- YINRYQVJJDJXRA-IBGZPJMESA-N CC(N1C)=NC(C=C(N2C[C@@H](C3=CN(C)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@@H](C3=CN(C)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O YINRYQVJJDJXRA-IBGZPJMESA-N 0.000 claims description 2
- PUXBWVHVLPXDRI-FQEVSTJZSA-N CC(N1C)=NC(C=C(N2C[C@@H](C3=CN=C(C)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@@H](C3=CN=C(C)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O PUXBWVHVLPXDRI-FQEVSTJZSA-N 0.000 claims description 2
- XDZBHZTZJVRCLT-IBGZPJMESA-N CC(N1C)=NC(C=C(N2C[C@@H](C3=CSC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@@H](C3=CSC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O XDZBHZTZJVRCLT-IBGZPJMESA-N 0.000 claims description 2
- GVYGDDXJIBUPQM-LIRRHRJNSA-N CC(N1C)=NC(C=C(N2C[C@@H]([C@@H]3COCC3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@@H]([C@@H]3COCC3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O GVYGDDXJIBUPQM-LIRRHRJNSA-N 0.000 claims description 2
- PUHLMSRSXKZTGM-MSOLQXFVSA-N CC(N1C)=NC(C=C(N2C[C@@H]([C@@H]3OCC3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@@H]([C@@H]3OCC3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O PUHLMSRSXKZTGM-MSOLQXFVSA-N 0.000 claims description 2
- GVYGDDXJIBUPQM-KUHUBIRLSA-N CC(N1C)=NC(C=C(N2C[C@@H]([C@H]3COCC3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@@H]([C@H]3COCC3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O GVYGDDXJIBUPQM-KUHUBIRLSA-N 0.000 claims description 2
- PUHLMSRSXKZTGM-ROUUACIJSA-N CC(N1C)=NC(C=C(N2C[C@@H]([C@H]3OCC3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@@H]([C@H]3OCC3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O PUHLMSRSXKZTGM-ROUUACIJSA-N 0.000 claims description 2
- LRYVKAZBSIIHFU-OAQYLSRUSA-N CC(N1C)=NC(C=C(N2C[C@H](C(C=C3)=CC=C3Cl)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C(C=C3)=CC=C3Cl)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O LRYVKAZBSIIHFU-OAQYLSRUSA-N 0.000 claims description 2
- RIUSFMUFAQAUGB-JOCHJYFZSA-N CC(N1C)=NC(C=C(N2C[C@H](C(C=C3)=CC=C3OC)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C(C=C3)=CC=C3OC)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O RIUSFMUFAQAUGB-JOCHJYFZSA-N 0.000 claims description 2
- MRYZTVMKWPRFJW-OAQYLSRUSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CC(C(F)(F)F)=CC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CC(C(F)(F)F)=CC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O MRYZTVMKWPRFJW-OAQYLSRUSA-N 0.000 claims description 2
- UNPQXTOPIFSZHH-LJQANCHMSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CC(Cl)=NC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CC(Cl)=NC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O UNPQXTOPIFSZHH-LJQANCHMSA-N 0.000 claims description 2
- KWEFMKRWCSRYEB-OAQYLSRUSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CC(OC(F)(F)F)=CC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CC(OC(F)(F)F)=CC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O KWEFMKRWCSRYEB-OAQYLSRUSA-N 0.000 claims description 2
- YSDOJRNALAXGEP-JOCHJYFZSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CC(OC)=CC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CC(OC)=CC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O YSDOJRNALAXGEP-JOCHJYFZSA-N 0.000 claims description 2
- XMRFVSIYXMRJJY-HXUWFJFHSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CC(OC)=NC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CC(OC)=NC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O XMRFVSIYXMRJJY-HXUWFJFHSA-N 0.000 claims description 2
- PAOBOWAPYZTHSE-HXUWFJFHSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CC(OCC(F)(F)F)=NC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CC(OCC(F)(F)F)=NC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O PAOBOWAPYZTHSE-HXUWFJFHSA-N 0.000 claims description 2
- CNGXBYKVEIZZRH-HXUWFJFHSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CC=CN=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CC=CN=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O CNGXBYKVEIZZRH-HXUWFJFHSA-N 0.000 claims description 2
- NKVNWTMJZKRBPI-HXUWFJFHSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CC=NC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CC=NC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O NKVNWTMJZKRBPI-HXUWFJFHSA-N 0.000 claims description 2
- ALVBVZLTBHLBOP-OAQYLSRUSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CN(C(CF)CF)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CN(C(CF)CF)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O ALVBVZLTBHLBOP-OAQYLSRUSA-N 0.000 claims description 2
- SDKJLXOEKHKBHD-FIWHBWSRSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CN(C(CF)F)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CN(C(CF)F)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O SDKJLXOEKHKBHD-FIWHBWSRSA-N 0.000 claims description 2
- HSCFDFUWZPJBKP-FIWHBWSRSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CN(C(CO)F)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CN(C(CO)F)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O HSCFDFUWZPJBKP-FIWHBWSRSA-N 0.000 claims description 2
- GHFIBZPMKMUHAG-GOSISDBHSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CN(C(F)(F)F)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CN(C(F)(F)F)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O GHFIBZPMKMUHAG-GOSISDBHSA-N 0.000 claims description 2
- SKBZHWRFRXSSKN-LJQANCHMSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CN(C)N=C3)OCC2)N=C2C(C=C3)=CC(F)=C3Cl)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CN(C)N=C3)OCC2)N=C2C(C=C3)=CC(F)=C3Cl)=C2C1=O SKBZHWRFRXSSKN-LJQANCHMSA-N 0.000 claims description 2
- RNRBOSQPTFKPOY-LJQANCHMSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CN(C)N=C3)OCC2)N=C2C(C=C3)=CC=C3Cl)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CN(C)N=C3)OCC2)N=C2C(C=C3)=CC=C3Cl)=C2C1=O RNRBOSQPTFKPOY-LJQANCHMSA-N 0.000 claims description 2
- YINRYQVJJDJXRA-LJQANCHMSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CN(C)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CN(C)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O YINRYQVJJDJXRA-LJQANCHMSA-N 0.000 claims description 2
- AQWRFOZPIBTHGX-LJQANCHMSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CN(C)N=C3)OCC2)N=C2C(C=CC(F)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CN(C)N=C3)OCC2)N=C2C(C=CC(F)=C3)=C3F)=C2C1=O AQWRFOZPIBTHGX-LJQANCHMSA-N 0.000 claims description 2
- JKYIQHNUYWKAQH-GOSISDBHSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CN(C)N=C3)OCC2)N=C2C3CCCC3)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CN(C)N=C3)OCC2)N=C2C3CCCC3)=C2C1=O JKYIQHNUYWKAQH-GOSISDBHSA-N 0.000 claims description 2
- QNNQAHOCVKZRJN-LJQANCHMSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CN(C)N=C3)OCC2)N=C2C3CCCCC3)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CN(C)N=C3)OCC2)N=C2C3CCCCC3)=C2C1=O QNNQAHOCVKZRJN-LJQANCHMSA-N 0.000 claims description 2
- FNJPYTWLIZQTAZ-OAQYLSRUSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CN(C4CC4)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CN(C4CC4)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O FNJPYTWLIZQTAZ-OAQYLSRUSA-N 0.000 claims description 2
- QQVGGWCCLVBRQY-JOCHJYFZSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CN(C4CCC4)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CN(C4CCC4)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O QQVGGWCCLVBRQY-JOCHJYFZSA-N 0.000 claims description 2
- UTSCACOSYSQKLJ-JOCHJYFZSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CN(C4CN(C)C4)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CN(C4CN(C)C4)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O UTSCACOSYSQKLJ-JOCHJYFZSA-N 0.000 claims description 2
- BVKLRSNOAOAPAZ-OAQYLSRUSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CN(C4COC4)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CN(C4COC4)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O BVKLRSNOAOAPAZ-OAQYLSRUSA-N 0.000 claims description 2
- FGBBETJZKSACER-LJQANCHMSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CN(CC(F)(F)F)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CN(CC(F)(F)F)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O FGBBETJZKSACER-LJQANCHMSA-N 0.000 claims description 2
- XIXLWOGPFYFUBS-HXUWFJFHSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CN(CCF)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CN(CCF)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O XIXLWOGPFYFUBS-HXUWFJFHSA-N 0.000 claims description 2
- FNKQRIBGJXYOQX-JOCHJYFZSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CN(CCN(C)C)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CN(CCN(C)C)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O FNKQRIBGJXYOQX-JOCHJYFZSA-N 0.000 claims description 2
- IGLDAXGHARWQGE-OAQYLSRUSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CN(CCOC)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CN(CCOC)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O IGLDAXGHARWQGE-OAQYLSRUSA-N 0.000 claims description 2
- PUXBWVHVLPXDRI-HXUWFJFHSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CN=C(C)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CN=C(C)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O PUXBWVHVLPXDRI-HXUWFJFHSA-N 0.000 claims description 2
- UKTKZYFFCPRBCC-GOSISDBHSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CNN=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CNN=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O UKTKZYFFCPRBCC-GOSISDBHSA-N 0.000 claims description 2
- XDZBHZTZJVRCLT-LJQANCHMSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=CSC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=CSC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O XDZBHZTZJVRCLT-LJQANCHMSA-N 0.000 claims description 2
- SWUQTSRTTXLLIF-GOSISDBHSA-N CC(N1C)=NC(C=C(N2C[C@H](C3=NOC(C4CC4)=N3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3=NOC(C4CC4)=N3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O SWUQTSRTTXLLIF-GOSISDBHSA-N 0.000 claims description 2
- OTMINHSXBRJLSW-GOSISDBHSA-N CC(N1C)=NC(C=C(N2C[C@H](C3CC3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H](C3CC3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O OTMINHSXBRJLSW-GOSISDBHSA-N 0.000 claims description 2
- GVYGDDXJIBUPQM-IFXJQAMLSA-N CC(N1C)=NC(C=C(N2C[C@H]([C@@H]3COCC3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H]([C@@H]3COCC3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O GVYGDDXJIBUPQM-IFXJQAMLSA-N 0.000 claims description 2
- PUHLMSRSXKZTGM-QZTJIDSGSA-N CC(N1C)=NC(C=C(N2C[C@H]([C@@H]3OCC3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H]([C@@H]3OCC3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O PUHLMSRSXKZTGM-QZTJIDSGSA-N 0.000 claims description 2
- GVYGDDXJIBUPQM-AUUYWEPGSA-N CC(N1C)=NC(C=C(N2C[C@H]([C@H]3COCC3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H]([C@H]3COCC3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O GVYGDDXJIBUPQM-AUUYWEPGSA-N 0.000 claims description 2
- PUHLMSRSXKZTGM-ZWKOTPCHSA-N CC(N1C)=NC(C=C(N2C[C@H]([C@H]3OCC3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N2C[C@H]([C@H]3OCC3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O PUHLMSRSXKZTGM-ZWKOTPCHSA-N 0.000 claims description 2
- GANLOBMOQAHBRI-NYHFZMIOSA-N CC(N1C)=NC(C=C([C@@H]2C[C@@H](C3=CC(OC)=NC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C([C@@H]2C[C@@H](C3=CC(OC)=NC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O GANLOBMOQAHBRI-NYHFZMIOSA-N 0.000 claims description 2
- IYYXTMOLMWIDMQ-NYHFZMIOSA-N CC(N1C)=NC(C=C([C@@H]2C[C@@H](C3=CC=CN=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C([C@@H]2C[C@@H](C3=CC=CN=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O IYYXTMOLMWIDMQ-NYHFZMIOSA-N 0.000 claims description 2
- VNHKBTQFPMVSIK-QKKBWIMNSA-N CC(N1C)=NC(C=C([C@@H]2C[C@@H](C3=CN(C)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C([C@@H]2C[C@@H](C3=CN(C)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O VNHKBTQFPMVSIK-QKKBWIMNSA-N 0.000 claims description 2
- NJOCDJDJDPTYPO-APPDUMDISA-N CC(N1C)=NC(C=C([C@@H]2C[C@H](C(O)=O)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C([C@@H]2C[C@H](C(O)=O)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O NJOCDJDJDPTYPO-APPDUMDISA-N 0.000 claims description 2
- GANLOBMOQAHBRI-OYHNWAKOSA-N CC(N1C)=NC(C=C([C@@H]2C[C@H](C3=CC(OC)=NC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C([C@@H]2C[C@H](C3=CC(OC)=NC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O GANLOBMOQAHBRI-OYHNWAKOSA-N 0.000 claims description 2
- IYYXTMOLMWIDMQ-OYHNWAKOSA-N CC(N1C)=NC(C=C([C@@H]2C[C@H](C3=CC=CN=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C([C@@H]2C[C@H](C3=CC=CN=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O IYYXTMOLMWIDMQ-OYHNWAKOSA-N 0.000 claims description 2
- VNHKBTQFPMVSIK-LHSJRXKWSA-N CC(N1C)=NC(C=C([C@@H]2C[C@H](C3=CN(C)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C([C@@H]2C[C@H](C3=CN(C)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O VNHKBTQFPMVSIK-LHSJRXKWSA-N 0.000 claims description 2
- BFKXXBTXGJAROO-NPMXOYFQSA-N CC(N1C)=NC(C=C([C@@H]2C[C@H](C3=CN(C4CC4)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C([C@@H]2C[C@H](C3=CN(C4CC4)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O BFKXXBTXGJAROO-NPMXOYFQSA-N 0.000 claims description 2
- GANLOBMOQAHBRI-QRQCRPRQSA-N CC(N1C)=NC(C=C([C@H]2C[C@@H](C3=CC(OC)=NC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C([C@H]2C[C@@H](C3=CC(OC)=NC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O GANLOBMOQAHBRI-QRQCRPRQSA-N 0.000 claims description 2
- IYYXTMOLMWIDMQ-QRQCRPRQSA-N CC(N1C)=NC(C=C([C@H]2C[C@@H](C3=CC=CN=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C([C@H]2C[C@@H](C3=CC=CN=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O IYYXTMOLMWIDMQ-QRQCRPRQSA-N 0.000 claims description 2
- VNHKBTQFPMVSIK-SZNDQCEHSA-N CC(N1C)=NC(C=C([C@H]2C[C@@H](C3=CN(C)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C([C@H]2C[C@@H](C3=CN(C)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O VNHKBTQFPMVSIK-SZNDQCEHSA-N 0.000 claims description 2
- BFKXXBTXGJAROO-CMJOXMDJSA-N CC(N1C)=NC(C=C([C@H]2C[C@@H](C3=CN(C4CC4)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C([C@H]2C[C@@H](C3=CN(C4CC4)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O BFKXXBTXGJAROO-CMJOXMDJSA-N 0.000 claims description 2
- GANLOBMOQAHBRI-IVZQSRNASA-N CC(N1C)=NC(C=C([C@H]2C[C@H](C3=CC(OC)=NC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C([C@H]2C[C@H](C3=CC(OC)=NC=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O GANLOBMOQAHBRI-IVZQSRNASA-N 0.000 claims description 2
- IYYXTMOLMWIDMQ-IVZQSRNASA-N CC(N1C)=NC(C=C([C@H]2C[C@H](C3=CC=CN=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C([C@H]2C[C@H](C3=CC=CN=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O IYYXTMOLMWIDMQ-IVZQSRNASA-N 0.000 claims description 2
- VNHKBTQFPMVSIK-SPLOXXLWSA-N CC(N1C)=NC(C=C([C@H]2C[C@H](C3=CN(C)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C([C@H]2C[C@H](C3=CN(C)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O VNHKBTQFPMVSIK-SPLOXXLWSA-N 0.000 claims description 2
- VHOWYIKPXHKHKI-UHFFFAOYSA-N CC(N1C)=NC2=CC(N3CC(C4=CN(C)N=C4)OCC3)=CC(C(C(F)=C3)=NC=C3Cl)=C2C1=O Chemical compound CC(N1C)=NC2=CC(N3CC(C4=CN(C)N=C4)OCC3)=CC(C(C(F)=C3)=NC=C3Cl)=C2C1=O VHOWYIKPXHKHKI-UHFFFAOYSA-N 0.000 claims description 2
- UKAQEOXVWSMIFQ-QFIPXVFZSA-N CC(N1C)=NC2=CC(N3C[C@@H](C4=CN(C)N=C4)OCC3)=CC(C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC2=CC(N3C[C@@H](C4=CN(C)N=C4)OCC3)=CC(C(C=CC(Cl)=C3)=C3F)=C2C1=O UKAQEOXVWSMIFQ-QFIPXVFZSA-N 0.000 claims description 2
- UKAQEOXVWSMIFQ-JOCHJYFZSA-N CC(N1C)=NC2=CC(N3C[C@H](C4=CN(C)N=C4)OCC3)=CC(C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC2=CC(N3C[C@H](C4=CN(C)N=C4)OCC3)=CC(C(C=CC(Cl)=C3)=C3F)=C2C1=O UKAQEOXVWSMIFQ-JOCHJYFZSA-N 0.000 claims description 2
- HRGUFZWUFQHZJS-OAQYLSRUSA-N CC(N1C2CC2)=NC(C=C(N2C[C@H](C3=CN(C)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C2CC2)=NC(C=C(N2C[C@H](C3=CN(C)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O HRGUFZWUFQHZJS-OAQYLSRUSA-N 0.000 claims description 2
- SUVHZLMYQURXJA-LJQANCHMSA-N CC(N1CC(F)(F)F)=NC(C=C(N2C[C@H](C3=CN(C)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1CC(F)(F)F)=NC(C=C(N2C[C@H](C3=CN(C)N=C3)OCC2)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O SUVHZLMYQURXJA-LJQANCHMSA-N 0.000 claims description 2
- MADXMGHHRYVQNB-LCNBYPMKSA-N CC(N1N=CC([C@@H](C2)OCCN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)=C1)F Chemical compound CC(N1N=CC([C@@H](C2)OCCN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)=C1)F MADXMGHHRYVQNB-LCNBYPMKSA-N 0.000 claims description 2
- DACSVUFCXLATSF-HXUWFJFHSA-N CC1=C([C@@H](C2)OCCN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)C=NN1C Chemical compound CC1=C([C@@H](C2)OCCN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)C=NN1C DACSVUFCXLATSF-HXUWFJFHSA-N 0.000 claims description 2
- DACSVUFCXLATSF-FQEVSTJZSA-N CC1=C([C@H](C2)OCCN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)C=NN1C Chemical compound CC1=C([C@H](C2)OCCN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)C=NN1C DACSVUFCXLATSF-FQEVSTJZSA-N 0.000 claims description 2
- BCJUQQUPFWHVFU-UHFFFAOYSA-N CC1=CC=C(C(C2)OCCC2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)C=N1 Chemical compound CC1=CC=C(C(C2)OCCC2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)C=N1 BCJUQQUPFWHVFU-UHFFFAOYSA-N 0.000 claims description 2
- SJQFBRYKOPYDKF-UHFFFAOYSA-N CC1=CC=C(C(C2)OCCN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)C=N1 Chemical compound CC1=CC=C(C(C2)OCCN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)C=N1 SJQFBRYKOPYDKF-UHFFFAOYSA-N 0.000 claims description 2
- SJQFBRYKOPYDKF-OAQYLSRUSA-N CC1=CC=C([C@@H](C2)OCCN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)C=N1 Chemical compound CC1=CC=C([C@@H](C2)OCCN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)C=N1 SJQFBRYKOPYDKF-OAQYLSRUSA-N 0.000 claims description 2
- SJQFBRYKOPYDKF-NRFANRHFSA-N CC1=CC=C([C@H](C2)OCCN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)C=N1 Chemical compound CC1=CC=C([C@H](C2)OCCN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)C=N1 SJQFBRYKOPYDKF-NRFANRHFSA-N 0.000 claims description 2
- MMLBCBYQSGYZPW-OAQYLSRUSA-N CC1=NC=CC([C@@H](C2)OCCN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)=C1 Chemical compound CC1=NC=CC([C@@H](C2)OCCN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)=C1 MMLBCBYQSGYZPW-OAQYLSRUSA-N 0.000 claims description 2
- KEPHMMCXHYEHNK-QMHKHESXSA-N CC1=NC=CC([C@@H](C2)OCC[C@@H]2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)=C1 Chemical compound CC1=NC=CC([C@@H](C2)OCC[C@@H]2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)=C1 KEPHMMCXHYEHNK-QMHKHESXSA-N 0.000 claims description 2
- MMLBCBYQSGYZPW-NRFANRHFSA-N CC1=NC=CC([C@H](C2)OCCN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)=C1 Chemical compound CC1=NC=CC([C@H](C2)OCCN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)=C1 MMLBCBYQSGYZPW-NRFANRHFSA-N 0.000 claims description 2
- KEPHMMCXHYEHNK-MWTRTKDXSA-N CC1=NC=CC([C@H](C2)OCC[C@H]2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)=C1 Chemical compound CC1=NC=CC([C@H](C2)OCC[C@H]2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)=C1 KEPHMMCXHYEHNK-MWTRTKDXSA-N 0.000 claims description 2
- DTRMACCBMLNXES-AWEZNQCLSA-N CC1=NOC([C@@H](CCC2)CN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)=N1 Chemical compound CC1=NOC([C@@H](CCC2)CN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)=N1 DTRMACCBMLNXES-AWEZNQCLSA-N 0.000 claims description 2
- UICLIEDTGICJNC-LJQANCHMSA-N CCCN(C(C)=NC1=C2C(C(C(F)=C3)=NC=C3Cl)=NC(N3C[C@H](C4=CN(C)N=C4)OCC3)=C1)C2=O Chemical compound CCCN(C(C)=NC1=C2C(C(C(F)=C3)=NC=C3Cl)=NC(N3C[C@H](C4=CN(C)N=C4)OCC3)=C1)C2=O UICLIEDTGICJNC-LJQANCHMSA-N 0.000 claims description 2
- FSAQPAKTPHEOIV-NRFANRHFSA-N CCCN(C(C)=NC1=C2C(C(C=CC(Cl)=C3)=C3F)=NC(N3C[C@@H](C4=CC=NN4C)OCC3)=C1)C2=O Chemical compound CCCN(C(C)=NC1=C2C(C(C=CC(Cl)=C3)=C3F)=NC(N3C[C@@H](C4=CC=NN4C)OCC3)=C1)C2=O FSAQPAKTPHEOIV-NRFANRHFSA-N 0.000 claims description 2
- JAEQFUIGIXRDNR-HSZRJFAPSA-N CCCN(C(C)=NC1=C2C(C(C=CC(Cl)=C3)=C3F)=NC(N3C[C@H](C4=CC=CC=C4)OCC3)=C1)C2=O Chemical compound CCCN(C(C)=NC1=C2C(C(C=CC(Cl)=C3)=C3F)=NC(N3C[C@H](C4=CC=CC=C4)OCC3)=C1)C2=O JAEQFUIGIXRDNR-HSZRJFAPSA-N 0.000 claims description 2
- FSAQPAKTPHEOIV-OAQYLSRUSA-N CCCN(C(C)=NC1=C2C(C(C=CC(Cl)=C3)=C3F)=NC(N3C[C@H](C4=CC=NN4C)OCC3)=C1)C2=O Chemical compound CCCN(C(C)=NC1=C2C(C(C=CC(Cl)=C3)=C3F)=NC(N3C[C@H](C4=CC=NN4C)OCC3)=C1)C2=O FSAQPAKTPHEOIV-OAQYLSRUSA-N 0.000 claims description 2
- LMAIYHIJGPZIMW-OAQYLSRUSA-N CCCN(C(C)=NC1=C2C(C(C=CC(Cl)=C3)=C3F)=NC(N3C[C@H](C4=CN(C)N=C4)OCC3)=C1)C2=O Chemical compound CCCN(C(C)=NC1=C2C(C(C=CC(Cl)=C3)=C3F)=NC(N3C[C@H](C4=CN(C)N=C4)OCC3)=C1)C2=O LMAIYHIJGPZIMW-OAQYLSRUSA-N 0.000 claims description 2
- MEUVBOWBDQNIEF-GOSISDBHSA-N CCN(C(C(F)(F)F)=NC1=C2C(C(C=CC(Cl)=C3)=C3F)=NC(N3C[C@H](C4=CN(C)N=C4)OCC3)=C1)C2=O Chemical compound CCN(C(C(F)(F)F)=NC1=C2C(C(C=CC(Cl)=C3)=C3F)=NC(N3C[C@H](C4=CN(C)N=C4)OCC3)=C1)C2=O MEUVBOWBDQNIEF-GOSISDBHSA-N 0.000 claims description 2
- DBNSTJMQQSMMTI-JOCHJYFZSA-N CCN(C(C)=NC1=C2C(C(C=CC(F)=C3)=C3F)=NC(N3C[C@H](C4=CC(C)=NC=C4)OCC3)=C1)C2=O Chemical compound CCN(C(C)=NC1=C2C(C(C=CC(F)=C3)=C3F)=NC(N3C[C@H](C4=CC(C)=NC=C4)OCC3)=C1)C2=O DBNSTJMQQSMMTI-JOCHJYFZSA-N 0.000 claims description 2
- HXPGVUCBWPQMTD-JOCHJYFZSA-N CCN(C(C)=NC1=C2C(C(C=CC(F)=C3)=C3F)=NC(N3C[C@H](C4=CN(C5CC5)N=C4)OCC3)=C1)C2=O Chemical compound CCN(C(C)=NC1=C2C(C(C=CC(F)=C3)=C3F)=NC(N3C[C@H](C4=CN(C5CC5)N=C4)OCC3)=C1)C2=O HXPGVUCBWPQMTD-JOCHJYFZSA-N 0.000 claims description 2
- WLGPNWFQWAIELE-HXUWFJFHSA-N CCN1N=CC([C@@H](C2)OCCN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)=C1 Chemical compound CCN1N=CC([C@@H](C2)OCCN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)=C1 WLGPNWFQWAIELE-HXUWFJFHSA-N 0.000 claims description 2
- RVORCNTUWXAFHU-QGZVFWFLSA-N CN1N=CC([C@@H](C2)OCCN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C(F)(F)F)N3C)=C2C3=O)=C1 Chemical compound CN1N=CC([C@@H](C2)OCCN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C(F)(F)F)N3C)=C2C3=O)=C1 RVORCNTUWXAFHU-QGZVFWFLSA-N 0.000 claims description 2
- ZWWZDQRPGHAHPT-HXUWFJFHSA-N CN1N=CC([C@@H](C2)OCCN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C3CC3)N3C)=C2C3=O)=C1 Chemical compound CN1N=CC([C@@H](C2)OCCN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C3CC3)N3C)=C2C3=O)=C1 ZWWZDQRPGHAHPT-HXUWFJFHSA-N 0.000 claims description 2
- KEIXXYYZNRFCTM-GOSISDBHSA-N CN1N=CC([C@@H](C2)OCCN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=CN3C)=C2C3=O)=C1 Chemical compound CN1N=CC([C@@H](C2)OCCN2C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=CN3C)=C2C3=O)=C1 KEIXXYYZNRFCTM-GOSISDBHSA-N 0.000 claims description 2
- WDZDIYLDXCPWTF-RBZFPXEDSA-N C[C@@H](CN(C1)C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)O[C@@H]1C1=CN(C)N=C1 Chemical compound C[C@@H](CN(C1)C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)O[C@@H]1C1=CN(C)N=C1 WDZDIYLDXCPWTF-RBZFPXEDSA-N 0.000 claims description 2
- IEFHZHACBFLILI-BUXKBTBVSA-N C[C@@H](CN(C1)C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)O[C@@H]1C1CC1 Chemical compound C[C@@H](CN(C1)C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)O[C@@H]1C1CC1 IEFHZHACBFLILI-BUXKBTBVSA-N 0.000 claims description 2
- WDZDIYLDXCPWTF-RNODOKPDSA-N C[C@@H](CN(C1)C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)O[C@H]1C1=CN(C)N=C1 Chemical compound C[C@@H](CN(C1)C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)O[C@H]1C1=CN(C)N=C1 WDZDIYLDXCPWTF-RNODOKPDSA-N 0.000 claims description 2
- IEFHZHACBFLILI-HXPMCKFVSA-N C[C@@H](CN(C1)C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)O[C@H]1C1CC1 Chemical compound C[C@@H](CN(C1)C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)O[C@H]1C1CC1 IEFHZHACBFLILI-HXPMCKFVSA-N 0.000 claims description 2
- WDZDIYLDXCPWTF-XCLFUZPHSA-N C[C@H](CN(C1)C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)O[C@@H]1C1=CN(C)N=C1 Chemical compound C[C@H](CN(C1)C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)O[C@@H]1C1=CN(C)N=C1 WDZDIYLDXCPWTF-XCLFUZPHSA-N 0.000 claims description 2
- IEFHZHACBFLILI-BLVKFPJESA-N C[C@H](CN(C1)C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)O[C@@H]1C1CC1 Chemical compound C[C@H](CN(C1)C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)O[C@@H]1C1CC1 IEFHZHACBFLILI-BLVKFPJESA-N 0.000 claims description 2
- WDZDIYLDXCPWTF-ZUOKHONESA-N C[C@H](CN(C1)C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)O[C@H]1C1=CN(C)N=C1 Chemical compound C[C@H](CN(C1)C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)O[C@H]1C1=CN(C)N=C1 WDZDIYLDXCPWTF-ZUOKHONESA-N 0.000 claims description 2
- IEFHZHACBFLILI-CWTRNNRKSA-N C[C@H](CN(C1)C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)O[C@H]1C1CC1 Chemical compound C[C@H](CN(C1)C(N=C2C(C=CC(Cl)=C3)=C3F)=CC(N=C(C)N3C)=C2C3=O)O[C@H]1C1CC1 IEFHZHACBFLILI-CWTRNNRKSA-N 0.000 claims description 2
- INVIJQRGTBVELZ-XCLFUZPHSA-N C[C@H](CO[C@@H](C1)C2=CN(C)N=C2)N1C(N=C1C(C=CC(Cl)=C2)=C2F)=CC(N=C(C)N2C)=C1C2=O Chemical compound C[C@H](CO[C@@H](C1)C2=CN(C)N=C2)N1C(N=C1C(C=CC(Cl)=C2)=C2F)=CC(N=C(C)N2C)=C1C2=O INVIJQRGTBVELZ-XCLFUZPHSA-N 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- 125000003282 alkyl amino group Chemical group 0.000 claims description 2
- 125000004566 azetidin-1-yl group Chemical group N1(CCC1)* 0.000 claims description 2
- 125000002393 azetidinyl group Chemical group 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000002883 imidazolyl group Chemical group 0.000 claims description 2
- 125000004274 oxetan-2-yl group Chemical group [H]C1([H])OC([H])(*)C1([H])[H] 0.000 claims description 2
- 125000003566 oxetanyl group Chemical group 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 2
- 125000002098 pyridazinyl group Chemical group 0.000 claims description 2
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 2
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims description 2
- 125000000335 thiazolyl group Chemical group 0.000 claims description 2
- 125000001544 thienyl group Chemical group 0.000 claims description 2
- 101000795117 Homo sapiens Triggering receptor expressed on myeloid cells 2 Proteins 0.000 description 3
- 102000048432 human TREM2 Human genes 0.000 description 3
- 238000000034 method Methods 0.000 description 2
- NBRFJYGDRUGWFX-UHFFFAOYSA-N CC(N1C)=NC(C=C(N(CC2)CC2C2=NC=CN2C)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O Chemical compound CC(N1C)=NC(C=C(N(CC2)CC2C2=NC=CN2C)N=C2C(C=CC(Cl)=C3)=C3F)=C2C1=O NBRFJYGDRUGWFX-UHFFFAOYSA-N 0.000 description 1
- BAAGVISFCGXCTD-UHFFFAOYSA-N CC1=CC(Cl)=CN=C1C1=NC(N2CC(C3=CN(C)N=C3)OCC2)=CC(N=C(C)N2C)=C1C2=O Chemical compound CC1=CC(Cl)=CN=C1C1=NC(N2CC(C3=CN(C)N=C3)OCC2)=CC(N=C(C)N2C)=C1C2=O BAAGVISFCGXCTD-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
Description
本明細書で引用される全ての参考文献、例えば、科学刊行物又は特許出願公開は、各参考文献が、全ての目的のためにその全体が参照により組み込まれることが具体的かつ個別に示されているのと同じ程度に、全ての目的のために参照により本明細書に組み込まれる。
非限定的に、本発明は以下の態様を含む。
[態様1]
式Iの化合物
X1が、(1)CH又はNであり、bが、単結合であるか、又は(2)C及びbが、二重結合であり、
X2が、CH2、CHF、CF2、O、又はNHであり、
任意に、R5が、存在せず、X2CR6基が、5又は6員ヘテロアリールを形成し、前記5員ヘテロアリールが、N、O、及びSから選択される1つのみの環原子、及び任意に、1つのみの更なるN環原子を含み、前記6員ヘテロアリールが、1つのみ又は2つのみのN環原子を含み、前記5又は6員ヘテロアリールが、ハロゲン、C1~3アルキル、又はC1~3アルコキシで任意に置換され、
各発生におけるX3が、独立して、CH又はNであり、
R1が、H、C1~6アルキル、C1~6ハロアルキル、又はC3~6シクロアルキルであり、
R2が、H、C1~3アルキル、C1~3ハロアルキル、又はC3~6シクロアルキルであり、
R3が、H又はC1~3アルキルであり、
R4が、H又はC1~3アルキルであり、
R5が、H又はC1~3アルキルであり、
R6が、C2~6アルキル、C1~6ハロアルキル、ジC1~3アルキルアミノ、-C(=O)O(C1~6アルキル)、C3~6シクロアルキル、C3~6ヘテロシクロアルキル、フェニル、5員ヘテロアリール、又は6員ヘテロアリールであり、
(1)C3~6シクロアルキル又はC3~6ヘテロシクロアルキルが、C=Oで任意に置換され、
(2)前記フェニル、5員ヘテロアリール、又は6員ヘテロアリール基が、独立して、ハロゲン、C1~6アルキル、C1~6ハロアルキル、C1~6アルコキシ、C1~6ハロアルコキシ、-(C1~3アルキル)O(C1~3アルキル)、-(C1~3アルキル)NH2、-(C1~3アルキル)NH(C1~3アルキル)、-(C1~3アルキル)N[(C1~3アルキル)(C1~3アルキル)]、-CN、C2~4アルケニル、C3~6シクロアルキル、フェニル、及びC3~6ヘテロシクロアルキルから選択される1~3個の置換基で任意に置換され、
前記サブセクション(2)のC1~6アルキル及びC1~6ハロアルキルが、OHで任意に置換され、
前記サブセクション(2)のC3~6ヘテロシクロアルキルが、ハロゲン、C1~3アルキル、及び-C(=O)O(C1~6アルキル)から選択される1~3個の置換基で任意に置換され、
R7が、C5~6シクロアルキル、C5~8スピロアルキル、C5~8トリシクロアル
キル、フェニル、又は6員ヘテロアリールであり、R7が、更に、独立して、ハロゲン、C1~3アルキル、及びC1~3ハロアルキルから選択される1~4個の置換基で任意に置換され、
nが、0又は1であるが、但し、X1がNであり、nが0であるときに、X2がNH又はOではないことを条件とする、式Iの化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。
[態様2]
前記化合物が、
5-(5-クロロ-3-メチル-2-ピリジニル)-2,3-ジメチル-7-(2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(3-メチル-3-フェニル-1-ピペリジン)ピリド[4,3-d]ピリミジン-4(3H)-オン、又は
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(3-(1-メチル-1H-イミダゾール-2-イル)-1-ピロリジニル)ピリド[4,3-d]ピリミジン-4(3H)-オンではない、態様1の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。
[態様3]
前記化合物が、式IIの化合物である、態様1又は2に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩
[態様4]
前記化合物が、式IIAの化合物である、態様1又は2に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩
[態様5]
前記化合物が、式IIBの化合物である、態様1又は2に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩
[態様6]
X1が、CHである、態様1~4のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。
[態様7]
X1が、Nである、態様1~4のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。
[態様8]
X2が、CH2、CF2、又はOである、態様1~7のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。
[態様9]
X2が、Oである、態様1~7のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。
[態様10]
式Iの
[態様11]
X3が、CHである、態様1~10のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。
[態様12]
X3が、Nである、態様1~10のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。
[態様13]
R1が、メチル、エチル、プロピル、-CH2CF3、シクロプロピル、又はシクロヘキシルである、態様1~12のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。
[態様14]
R1が、メチルである、態様1~12のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。
[態様15]
R2が、H、メチル、トリフルオロメチル、又はシクロプロピルである、態様1~14のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。
[態様16]
R2が、メチルである、態様1~14のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。
[態様17]
R3が、H又はメチルである、態様1~16のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。
[態様18]
R3が、Hである、態様1~16のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。
[態様19]
R4が、H又はメチルである、態様1~18のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。
[態様20]
R4が、Hである、態様1~18のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。
[態様21]
R5が、H又はメチルである、態様1~20のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。
[態様22]
R5が、Hである、態様1~20のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。
[態様23]
R6が、ジフルオロメチル、トリフルオロメチル、-CH2CF3、ジメチルアミノ、-C(=O)OCH2CH3、任意に置換されたシクロプロピル、任意に置換されたシクロブチル、任意に置換されたオキセタニル、任意に置換されたアゼチジニル、任意に置換されたテトラヒドロフラニル、任意に置換されたピロリジニル、任意に置換されたフェニル、任意に置換されたピラゾリル、任意に置換されたイミダゾリル、任意に置換された1,3-オキサゾリル、任意に置換された1,2,4-オキサジアゾリル、任意に置換された1,3,4-オキサジアゾリル、任意に置換されたチオフェニル、任意に置換されたチアゾリル、任意に置換されたピリジニル、任意に置換されたピリダジニル、又は任意に置換されたピリミジニルである、態様1~22のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。
[態様24]
R6が、ジフルオロメチル、トリフルオロメチル、-CH2CF3、ジメチルアミノ、-C(=O)OCH2CH3、シクロプロピル、シクロブチル、オキセタン-2-イル、アゼチジン-1-イル、テトラヒドロフラン-3-イル、
[態様25]
R6が、
[態様26]
R7が、任意に置換されたC5~6シクロアルキル、任意に置換されたフェニル、又は任意に置換された6員ヘテロアリールである、態様1~25のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。
[態様27]
R7が、任意に置換されたC5~6シクロアルキル、任意に置換されたフェニル、又は任意に置換されたピリジニルである、態様1~25のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。
[態様28]
R7が、任意に置換されたフェニルである、態様1~25のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。
[態様29]
R7が、
[態様30]
R7が、
[態様31]
nが、0である、態様1~9及び11~30のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。
[態様32]
nが、1である、態様1~30のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。
[態様33]
前記化合物が、表Aの化合物、若しくはその互変異性体、又は前記表Aの化合物若しくはその互変異性体の薬学的に許容される塩である、態様1に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。
[態様34]
前記化合物が、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)-4(3H)-キナゾリノン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)-4(3H)-キナゾリノン、
5-(4-クロロフェニル)-2,3-ジメチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロフェニル)-2,3-ジメチル-7-((2R)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-3-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(2,4-ジフルオロフェニル)-2,3-ジメチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
2,3-ジメチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)-5-(2,3,4-トリフルオロフェニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
2,3-ジメチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)-5-(2,4,5-トリフルオロフェニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2,5-ジフルオロフェニル)-2,3-ジメチル-7-((2S
)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(2-フルオロ-4-メチルフェニル)-2,3-ジメチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(2-フルオロ-4-(トリフルオロメチル)フェニル)-2,3-ジメチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2,3-ジフルオロフェニル)-2,3-ジメチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(5-クロロ-3-フルオロ-2-ピリジニル)-2,3-ジメチル-7-(2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)-4(3H)-キナゾリノン、
2,3-ジメチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)-5-(6-(トリフルオロメチル)-3-ピリジニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-3-シクロヘキシル-2-メチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2-メチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)-3-(2,2,2-トリフルオロエチル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-3-シクロプロピル-2-メチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
±5-(5-クロロ-3-フルオロ-2-ピリジニル)-2-メチル-7-(2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)-3-プロピルピリド-[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(1-エチル-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R)-2-(1-エチル-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S,5R)-5-メチル-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R,5R)-5-メチル-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R,6R)-2-メチル-6-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R,6S)-2-メチル-6-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S,6R)-2-メチル-6-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S,6S)-2-メチル-6-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(2-メチル-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-シクロプロピル-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2-シクロブチル-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S,6R)-2-シクロプロピル-6-メチル-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S,6S)-2-シクロプロピル-6-メチル-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R,6R)-2-シクロプロピル-6-メチル-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R,6S)-2-シクロプロピル-6-メチル-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-((2R)-2-オキセタニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-((2S)-2-オキセタニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-((2S)-2-オキセタニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-((2R)-2-オキセタニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-((3S)-テトラヒドロ-3-フラニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-((3S)-テトラヒドロ-3-フラニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-((3R)-テトラヒドロ-3-フラニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-((3R)-テトラヒドロ-3-フラニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(3-ピリジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-(3-ピリジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-(4-ピリジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(4-ピリジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(2-(4-ピリダニジル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(2-(5-ピリミジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(2-(1-メチル-1H-ピラゾール-5-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(2-(2,2,2-トリフルオロエチル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-(チオフェン-3-イル)モルホリノ)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(3-チオフェニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-(5-メチル-1,2,4-オキサジアゾール-3-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(5-メチル-1,2,4-オキサジアゾール-3-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(5-メチル-1,3,4-オキサジアゾール-2-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-(5-メチル-1,3,4-オキサジアゾール-2-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(2-(6-メチル-3-ピリジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(2-メチル-4-ピリジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-(2-メチル-4-ピリジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジ
ン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(2-(2-メチル-4-ピリミジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-(2-メチル-5-ピリミジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(2-メチル-5-ピリミジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R)-2-(1,5-ジメチル-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(1,5-ジメチル-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-(2-(1,3-ジメチル-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-(2-(5-フルオロ-3-ピリジニル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-(2-(5-エチル-1,3,4-オキサジアゾール-2-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S,6S)-2-メチル-6-(3-チオフェニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S,6R)-2-メチル-6-(3-チオフェニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R,6S)-2-メチル-6-(3-チオフェニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R,6R)-2-メチル-6-(3-チオフェニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(2-(4-メチル-1,3-チアゾール-2-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R)-2-(2,6-ジメチル-4-ピリジニル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(2,6-ジメチル-4-ピリジニル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(4-メトキシフェニル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R)-2-(4-メトキシフ
ェニル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(3-メトキシフェニル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R)-2-(3-メトキシフェニル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(2-メトキシ-4-ピリジニル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R)-2-(2-メトキシ-4-ピリジニル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R)-2-(5-シクロプロピル-1,2,4-オキサジアゾール-3-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(5-シクロプロピル-1,2,4-オキサジアゾール-3-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R)-2-(4-クロロフェニル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(4-クロロフェニル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R)-2-(2-クロロ-4-ピリジニル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(2-クロロ-4-ピリジニル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
4-(4-(5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-4-オキソ-3,4-ジヒドロピリド[4,3-d]ピリミジン-7-イル)-2-モルホリニル)ベンゾニトリル、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(3-(トリフルオロメチル)フェニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-(3-(トリフルオロメチル)フェニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(2-(5-フェニル-1,2,4-オキサジアゾール-3-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(2-(2-(トリフルオロメチル)-4-ピリジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-(2-(2,2,2-トリフルオロエトキシ)-4-ピリジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(2-(2,2,2-トリフルオロエトキシ)-4-ピリジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-(3-(トリフルオロメトキシ)フェニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(3-(トリフルオロメトキシ)フェニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(2-(1-メチル-1H-ピラゾール-4-イル)-1-ピペリジニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((3R)-3-(1-メチル-1H-ピラゾール-4-イル)-1-ピペリジニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-(3,4-ジヒドロ-2,6-ナフチリジン-2(1H)-イル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-(3,4-ジヒドロ-2,7-ナフチリジン-2(1H)-イル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(1-メチル-1,4,5,7-テトラヒドロ-6H-ピラゾロ[3,4-c]ピリジン-6-イル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(3-(1,3-オキサゾール-5-イル)-1-ピペリジニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(3-(5-オキソ-3-ピロリジニル)-1-ピペリジニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((3S)-3-(1H-ピラゾール-4-イル)-1-ピペリジニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((3R)-3-(1H-ピラゾール-4-イル)-1-ピペリジニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-(3-(ジメチルアミノ)-1-ピペリジニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
7-(3-(1-アゼチジニル)-1-ピペリジニル)-5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((3R)-3-(3-メチル-1,2,4-オキサジアゾール-5-イル)-1-ピペリジニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((3S)-3-(3-メチル-1,2,4-オキサジアゾール-5-イル)-1-ピペリジニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((3S)-3-(4-ピリジニル)-1-ピペリジニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((3R)-3-(4-ピリジニル)-1-ピペリジニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
7-(8-クロロ-3,4-ジヒドロ-2,7-ナフチリジン-2(1H)-イル)-5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5’-(4-クロロ-2-フルオロフェニル)-4-メトキシ-2’,3’-ジメチル-7,8-ジヒドロ-5H-[6,7’-ビピリド[4,3-d]ピリミジン]-4’(3’H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((3R)-4,4-ジフルオロ-3-(1-メチル-1H-ピラゾール-4-イル)-1-ピペリジニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((3S)-4,4-ジフルオロ-3-(1-メチル-1H-ピラゾール-4-イル)-1-ピペリジニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(3-(トリフルオロメチル)-1-ピロリジニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-(3-(ジフルオロメチル)-1-ピロリジニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(3-(3-ピリジニル)-1-ピロリジニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(1-(2-プロパニル)-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(1-シクロブチル-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(1-(3-オキセタニル)-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(1-(2,2,2-トリフルオロエチル)-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(1-(2-メトキシエチル)-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(1-(2-フルオロエチル)-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(1-(1-フルオロエチル)-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(1-(1-フルオロ-2-ヒドロキシエチル)-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(1-(3,3-ジフルオロシクロブチル)-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(1-(2-(ジメチルアミノ)エチル)-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(1-(1,3-ジフルオロ-2-プロパニル)-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
2-メチル-2-プロパニル3-(4-((2S)-4-(5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-4-オキソ-3,4-ジヒドロピリド[4,3-d]ピリミジン-7-イル)-2-モルホリニル)-1H-ピラゾール-1-イル)-1-アゼチジンカルボキシレート、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(1-(1,2-ジフルオロエチル)-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(1-シクロプロピル-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(1-エテニル-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(1-(1-メチル-3-アゼチジニル)-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(6-メチル-3-ピリジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-(6-メチル-3-ピリジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(1-(トリフルオロメチル)-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2-シクロプロピル-3-メチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-3-メチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)-2-(トリフルオロメチル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-3-エチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)-2-(トリフルオロメチル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2-メチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-3-エチル-2-メチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-3-エチル-2-メチル-7-((2S)-2-(5-メチル-1,2,4-オキサジアゾール-3-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-3-エチル-2-メチル-7-((2R
)-2-(5-メチル-1,2,4-オキサジアゾール-3-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-3-エチル-2-メチル-7-((2S)-2-(2-メチル-4-ピリジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(2,4-ジフルオロフェニル)-3-エチル-2-メチル-7-((2S)-2-(2-メチル-4-ピリジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
7-((2S)-2-(1-シクロプロピル-1H-ピラゾール-4-イル)-4-モルホリニル)-5-(2,4-ジフルオロフェニル)-3-エチル-2-メチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2-メチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)-3-プロピルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(5-クロロ-3-フルオロ-2-ピリジニル)-2-メチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)-3-プロピルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2-メチル-7-((2S)-2-(1-メチル-1H-ピラゾール-5-イル)-4-モルホリニル)-3-プロピルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2-メチル-7-((2R)-2-(1-メチル-1H-ピラゾール-5-イル)-4-モルホリニル)-3-プロピルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R)-2-(ジフルオロメチル)-4-モルホリニル)-2-メチル-3-プロピルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2-メチル-7-((2S)-2-フェニル-4-モルホリニル)-3-プロピルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-3-メチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-シクロヘキシル-2,3-ジメチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-シクロペンチル-2,3-ジメチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R,4R)-2-(1-メチル-1H-ピラゾール-4-イル)テトラヒドロ-2H-ピラン-4-イル)ピリド[4,3-d]ピリミジン-4(3H)-オン及び5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S,4S)-2-(1-メチル-1H-ピラゾール-4-イル)テトラヒドロ-2H-ピラン-4-イル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R,4S)-2-(1-メチル-1H-ピラゾール-4-イル)テトラヒドロ-2H-ピラン-4-イル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S,4R)-2-(1-メチル-1H-ピラゾール-4-イル)テトラヒドロ-2H-ピラン-4-イル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(6-(1-メチル-1H-ピラゾール-4-イル)-3,6-ジヒドロ-2H-ピラン-4-イル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R,4S)-2-(1-シクロプロピル-1H-ピラゾール-4-イル)テトラヒドロ-2H-ピラン-4-イル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S,4R)-2-(1-シクロプロピル-1H-ピラゾール-4-イル)テトラヒドロ-2H-ピラン-4-イル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
(2R,4S)-4-(5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-4-オキソ-3,4-ジヒドロピリド[4,3-d]ピリミジン-7-イル)テトラヒドロ-2H-ピラン-2-カルボン酸エチル及び(2S,4R)-4-(5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-4-オキソ-3,4-ジヒドロピリド[4,3-d]ピリミジン-7-イル)テトラヒドロ-2H-ピラン-2-カルボン酸エチル、
(2S,4S)-4-(5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-4-オキソ-3,4-ジヒドロピリド[4,3-d]ピリミジン-7-イル)テトラヒドロ-2H-ピラン-2-カルボン酸エチル及び(2R,4R)-4-(5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-4-オキソ-3,4-ジヒドロピリド[4,3-d]ピリミジン-7-イル)テトラヒドロ-2H-ピラン-2-カルボン酸エチル、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R,4S)-2-(2-メチル-4-ピリジニル)テトラヒドロ-2H-ピラン-4-イル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S,4R)-2-(2-メチル-4-ピリジニル)テトラヒドロ-2H-ピラン-4-イル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(2-(6-メチルピリジン-3-イル)テトラヒドロ-2H-ピラン-4-イル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R,4S)-2-(2-メトキシ-4-ピリジニル)テトラヒドロ-2H-ピラン-4-イル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S,4R)-2-(2-メトキシ-4-ピリジニル)テトラヒドロ-2H-ピラン-4-イル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R,4R)-2-(2-メトキシ-4-ピリジニル)テトラヒドロ-2H-ピラン-4-イル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S,4S)-2-(2-メトキシ-4-ピリジニル)テトラヒドロ-2H-ピラン-4-イル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R,4R)-2-(3-ピリジニル)テトラヒドロ-2H-ピラン-4-イル)ピリド[4,3-d]ピリミジン-4(3H)-オン及び5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S,4S)-2-(3-ピリジニル)テトラヒドロ-2H-ピラン-4-イル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R,4S)-2-(3-ピリジニル)テトラヒドロ-2H-ピラン-4-イル)ピリド[4,3-d]ピリミジン-4(3H)-オン、又は
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S,4R)-2-(3-ピリジニル)テトラヒドロ-2H-ピラン-4-イル)ピリド[4,3-d]ピリミジン-4(3H)-オンである、態様1に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。
[態様35]
前記化合物が、
[態様36]
前記化合物が、
[態様37]
前記化合物が、
[態様38]
前記化合物が、
[態様39]
前記化合物が、
[態様40]
前記化合物が、
[態様41]
前記化合物が、
[態様42]
前記化合物が、
[態様43]
態様1~42のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩と、薬学的に許容される賦形剤と、を含む、薬学的組成物。
[態様44]
薬物として使用するための、態様1~42のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩、又は態様43に記載の薬学的組成物。
[態様45]
ヒトTREM2の機能の喪失に関連する状態の治療又は予防に使用するための、態様1~42のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩、又は態様43に記載の薬学的組成物。
[態様46]
パーキンソン病、関節リウマチ、アルツハイマー病、那須ハコラ病、前頭側頭型認知症、多発性硬化症、プリオン病、若しくは脳卒中の治療又は予防に使用するための、態様1~42のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩、又は態様43に記載の薬学的組成物。
[態様47]
ヒトTREM2の機能の喪失に関連する状態を治療又は予防するための薬物の調製における、態様1~42のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩、又は態様43に記載の薬学的組成物の使用。
[態様48]
パーキンソン病、関節リウマチ、アルツハイマー病、那須ハコラ病、前頭側頭型認知症、多発性硬化症、プリオン病、若しくは脳卒中を治療又は予防するための薬物の調製における、態様1~42のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩、又は態様43に記載の薬学的組成物の使用。
[態様49]
ヒトTREM2の機能の喪失に関連する状態を治療又は予防することを必要とする対象においてそれを行う方法であって、治療有効量の態様1~42のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩を前記対象に投与することを含む、方法。
[態様50]
パーキンソン病、関節リウマチ、アルツハイマー病、那須ハコラ病、前頭側頭型認知症、多発性硬化症、プリオン病、若しくは脳卒中を治療又は予防することを必要とする対象においてそれを行う方法であって、治療有効量の態様1~42のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩を前記対象に投与することを含む、方法。
All references cited in this specification, e.g., scientific publications or published patent applications, are hereby incorporated by reference for all purposes to the same extent as if each reference was specifically and individually indicated to be incorporated by reference in its entirety for all purposes.
Without being limited thereto, the present invention includes the following aspects.
[Aspect 1]
Compounds of Formula I
X1 is (1) CH or N, and b is a single bond, or (2) C and b are double bonds;
X2 is CH2 , CHF, CF2 , O, or NH;
Optionally, R 5 is absent and the X 2 CR 6 groups form a 5- or 6-membered heteroaryl, said 5-membered heteroaryl containing only one ring atom selected from N, O and S, and optionally only one further N ring atom, said 6-membered heteroaryl containing only one or only two N ring atoms, said 5- or 6-membered heteroaryl being optionally substituted with halogen, C 1-3 alkyl, or C 1-3 alkoxy;
X3 at each occurrence is independently CH or N;
R 1 is H, C 1-6 alkyl, C 1-6 haloalkyl, or C 3-6 cycloalkyl;
R2 is H, C1-3 alkyl, C1-3 haloalkyl, or C3-6 cycloalkyl;
R3 is H or C1-3 alkyl;
R 4 is H or C 1-3 alkyl;
R 5 is H or C 1-3 alkyl;
R 6 is C 2-6 alkyl, C 1-6 haloalkyl, diC 1-3 alkylamino, -C(=O)O(C 1-6 alkyl), C 3-6 cycloalkyl, C 3-6 heterocycloalkyl, phenyl, 5-membered heteroaryl, or 6-membered heteroaryl;
(1) C 3-6 cycloalkyl or C 3-6 heterocycloalkyl is optionally substituted with C═O;
(2) the phenyl, 5-membered heteroaryl, or 6-membered heteroaryl group is optionally substituted with 1 to 3 substituents independently selected from halogen, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, -( C1-3 alkyl)O(C1-3 alkyl ), -( C1-3 alkyl) NH2 , -( C1-3 alkyl)NH( C1-3 alkyl), -( C1-3 alkyl)N[( C1-3 alkyl)( C1-3 alkyl)], -CN, C2-4 alkenyl, C3-6 cycloalkyl, phenyl, and C3-6 heterocycloalkyl;
the C 1-6 alkyl and C 1-6 haloalkyl of subsection (2) are optionally substituted with OH;
the C3-6 heterocycloalkyl of subsection (2) is optionally substituted with 1 to 3 substituents selected from halogen, C1-3 alkyl, and -C(=O)O( C1-6 alkyl);
R 7 is a C 5-6 cycloalkyl, a C 5-8 spiroalkyl, a C 5-8 tricycloalkyl, a phenyl, or a 6-membered heteroaryl, R 7 is optionally further substituted with 1 to 4 substituents independently selected from halogen, C 1-3 alkyl, and C 1-3 haloalkyl;
A compound of formula I, or a tautomer thereof, wherein n is 0 or 1, with the proviso that when X1 is N and n is 0, then X2 is not NH or O; or a pharma- ceutically acceptable salt of said compound or said tautomer.
[Aspect 2]
The compound is
5-(5-chloro-3-methyl-2-pyridinyl)-2,3-dimethyl-7-(2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
A compound of embodiment 1 which is not 5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(3-methyl-3-phenyl-1-piperidine)pyrido[4,3-d]pyrimidin-4(3H)-one or 5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(3-(1-methyl-1H-imidazol-2-yl)-1-pyrrolidinyl)pyrido[4,3-d]pyrimidin-4(3H)-one, or a tautomer thereof, or a pharma- ceutically acceptable salt of said compound or said tautomer.
[Aspect 3]
3. The compound according to claim 1 or 2, wherein the compound is a compound of formula II, or a tautomer thereof, or a pharma- ceutically acceptable salt of the compound or the tautomer.
[Aspect 4]
3. The compound according to claim 1 or 2, wherein the compound is a compound of formula IIA, or a tautomer thereof, or a pharma- ceutically acceptable salt of the compound or the tautomer.
[Aspect 5]
3. The compound according to claim 1 or 2, wherein the compound is a compound of formula IIB, or a tautomer thereof, or a pharma- ceutically acceptable salt of the compound or the tautomer.
[Aspect 6]
A compound according to any one of aspects 1 to 4, wherein X 1 is CH; or a tautomer thereof; or a pharma- ceutically acceptable salt of said compound or said tautomer.
[Aspect 7]
A compound according to any one of aspects 1 to 4, wherein X 1 is N; or a tautomer thereof; or a pharma- ceutically acceptable salt of said compound or said tautomer.
[Aspect 8]
A compound according to any one of aspects 1 to 7, wherein X 2 is CH 2 , CF 2 , or O; or a tautomer thereof; or a pharma- ceutically acceptable salt of said compound or said tautomer.
[Aspect 9]
A compound according to any one of aspects 1 to 7, wherein X2 is O; or a tautomer thereof; or a pharma- ceutically acceptable salt of said compound or said tautomer.
[Aspect 10]
Of formula I
[Aspect 11]
A compound according to any one of the preceding aspects, wherein X3 is CH; or a tautomer thereof; or a pharma- ceutically acceptable salt of said compound or said tautomer.
[Aspect 12]
The compound according to any one of aspects 1 to 10, wherein X3 is N; or a tautomer thereof; or a pharma- ceutically acceptable salt of said compound or said tautomer.
[Aspect 13]
Aspect 13. The compound according to any one of aspects 1 to 12, wherein R 1 is methyl, ethyl, propyl, -CH 2 CF 3 , cyclopropyl, or cyclohexyl; or a tautomer thereof; or a pharma- ceutically acceptable salt of said compound or said tautomer.
[Aspect 14]
13. The compound according to any one of aspects 1 to 12, wherein R 1 is methyl; or a tautomer thereof; or a pharma- ceutically acceptable salt of said compound or said tautomer.
[Aspect 15]
A compound according to any one of the preceding aspects, wherein R 2 is H, methyl, trifluoromethyl, or cyclopropyl; or a tautomer thereof; or a pharma- ceutically acceptable salt of said compound or said tautomer.
[Aspect 16]
A compound according to any one of the preceding aspects, wherein R 2 is methyl; or a tautomer thereof; or a pharma- ceutically acceptable salt of said compound or said tautomer.
[Aspect 17]
17. The compound according to any one of aspects 1 to 16, wherein R 3 is H or methyl; or a tautomer thereof; or a pharma- ceutically acceptable salt of said compound or said tautomer.
[Aspect 18]
17. The compound according to any one of the preceding aspects, wherein R 3 is H, or a tautomer thereof, or a pharma- ceutically acceptable salt of said compound or said tautomer.
[Aspect 19]
19. The compound according to any one of the preceding aspects, wherein R 4 is H or methyl; or a tautomer thereof; or a pharma- ceutically acceptable salt of said compound or said tautomer.
[Aspect 20]
A compound according to any one of the preceding aspects, wherein R 4 is H, or a tautomer thereof, or a pharma- ceutically acceptable salt of said compound or said tautomer.
[Aspect 21]
21. The compound according to any one of aspects 1 to 20, wherein R 5 is H or methyl; or a tautomer thereof; or a pharma- ceutically acceptable salt of said compound or said tautomer.
[Aspect 22]
21. The compound according to any one of aspects 1 to 20, wherein R 5 is H, or a tautomer thereof, or a pharma- ceutically acceptable salt of said compound or said tautomer.
[Aspect 23]
23. The compound according to any one of aspects 1 to 22, wherein R 6 is difluoromethyl, trifluoromethyl, -CH 2 CF 3 , dimethylamino, -C(═O)OCH 2 CH 3 , optionally substituted cyclopropyl, optionally substituted cyclobutyl, optionally substituted oxetanyl, optionally substituted azetidinyl, optionally substituted tetrahydrofuranyl, optionally substituted pyrrolidinyl, optionally substituted phenyl, optionally substituted pyrazolyl, optionally substituted imidazolyl, optionally substituted 1,3-oxazolyl, optionally substituted 1,2,4-oxadiazolyl, optionally substituted 1,3,4-oxadiazolyl, optionally substituted thiophenyl, optionally substituted thiazolyl, optionally substituted pyridinyl, optionally substituted pyridazinyl, or optionally substituted pyrimidinyl, or a pharma- ceutically acceptable salt of said compound or said tautomer.
[Aspect 24]
R 6 is difluoromethyl, trifluoromethyl, —CH 2 CF 3 , dimethylamino, —C(═O)OCH 2 CH 3 , cyclopropyl, cyclobutyl, oxetan-2-yl, azetidin-1-yl, tetrahydrofuran-3-yl,
[Aspect 25]
R6 is
[Aspect 26]
26. The compound according to any one of the preceding aspects, wherein R 7 is optionally substituted C 5-6 cycloalkyl, optionally substituted phenyl, or optionally substituted 6-membered heteroaryl; or a tautomer thereof; or a pharma- ceutically acceptable salt of said compound or said tautomer.
[Aspect 27]
A compound according to any one of the preceding aspects, wherein R 7 is optionally substituted C 5-6 cycloalkyl, optionally substituted phenyl, or optionally substituted pyridinyl; or a tautomer thereof; or a pharma- ceutically acceptable salt of said compound or said tautomer.
[Aspect 28]
26. The compound according to any one of the preceding aspects, wherein R 7 is optionally substituted phenyl; or a tautomer thereof; or a pharma- ceutically acceptable salt of said compound or said tautomer.
[Aspect 29]
R7 is
[Aspect 30]
R7 is
[Aspect 31]
The compound according to any one of aspects 1 to 9 and 11 to 30, wherein n is 0; or a tautomer thereof; or a pharma- ceutically acceptable salt of said compound or said tautomer.
[Aspect 32]
31. The compound according to any one of aspects 1 to 30, wherein n is 1, or a tautomer thereof, or a pharma- ceutically acceptable salt of said compound or said tautomer.
[Aspect 33]
2. The compound or tautomer thereof according to aspect 1, wherein said compound is a compound of Table A, or a tautomer thereof, or a pharma- ceutically acceptable salt of said compound or said tautomer.
[Aspect 34]
The compound is
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)-4(3H)-quinazolinone,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)-4(3H)-quinazolinone,
5-(4-chlorophenyl)-2,3-dimethyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chlorophenyl)-2,3-dimethyl-7-((2R)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-3-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(2,4-difluorophenyl)-2,3-dimethyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
2,3-dimethyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)-5-(2,3,4-trifluorophenyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
2,3-dimethyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)-5-(2,4,5-trifluorophenyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2,5-difluorophenyl)-2,3-dimethyl-7-((2S
)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(2-fluoro-4-methylphenyl)-2,3-dimethyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(2-fluoro-4-(trifluoromethyl)phenyl)-2,3-dimethyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2,3-difluorophenyl)-2,3-dimethyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(5-chloro-3-fluoro-2-pyridinyl)-2,3-dimethyl-7-(2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)-4(3H)-quinazolinone,
2,3-dimethyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)-5-(6-(trifluoromethyl)-3-pyridinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-3-cyclohexyl-2-methyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2-methyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)-3-(2,2,2-trifluoroethyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-3-cyclopropyl-2-methyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
±5-(5-chloro-3-fluoro-2-pyridinyl)-2-methyl-7-(2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)-3-propylpyrido-[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(1-ethyl-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R)-2-(1-ethyl-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S,5R)-5-methyl-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R,5R)-5-methyl-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R,6R)-2-methyl-6-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R,6S)-2-methyl-6-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S,6R)-2-methyl-6-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S,6S)-2-methyl-6-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(2-methyl-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-cyclopropyl-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2-cyclobutyl-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S,6R)-2-cyclopropyl-6-methyl-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S,6S)-2-cyclopropyl-6-methyl-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R,6R)-2-cyclopropyl-6-methyl-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R,6S)-2-cyclopropyl-6-methyl-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-((2R)-2-oxetanyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-((2S)-2-oxetanyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-((2S)-2-oxetanyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-((2R)-2-oxetanyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-((3S)-tetrahydro-3-furanyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-((3S)-tetrahydro-3-furanyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-((3R)-tetrahydro-3-furanyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-((3R)-tetrahydro-3-furanyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(3-pyridinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-(3-pyridinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-(4-pyridinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(4-pyridinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(2-(4-pyridanidyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(2-(5-pyrimidinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(2-(1-methyl-1H-pyrazol-5-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(2-(2,2,2-trifluoroethyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-(thiophen-3-yl)morpholino)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(3-thiophenyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(5-methyl-1,3,4-oxadiazol-2-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-(5-methyl-1,3,4-oxadiazol-2-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(2-(6-methyl-3-pyridinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(2-methyl-4-pyridinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-(2-methyl-4-pyridinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(2-(2-methyl-4-pyrimidinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-(2-methyl-5-pyrimidinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(2-methyl-5-pyrimidinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R)-2-(1,5-dimethyl-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(1,5-dimethyl-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-(2-(1,3-dimethyl-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-(2-(5-fluoro-3-pyridinyl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-(2-(5-ethyl-1,3,4-oxadiazol-2-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S,6S)-2-methyl-6-(3-thiophenyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S,6R)-2-methyl-6-(3-thiophenyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R,6S)-2-methyl-6-(3-thiophenyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R,6R)-2-methyl-6-(3-thiophenyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(2-(4-methyl-1,3-thiazol-2-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R)-2-(2,6-dimethyl-4-pyridinyl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(2,6-dimethyl-4-pyridinyl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(4-methoxyphenyl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R)-2-(4-methoxyphenyl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(3-methoxyphenyl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R)-2-(3-methoxyphenyl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(2-methoxy-4-pyridinyl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R)-2-(2-methoxy-4-pyridinyl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R)-2-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R)-2-(4-chlorophenyl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(4-chlorophenyl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R)-2-(2-chloro-4-pyridinyl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(2-chloro-4-pyridinyl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
4-(4-(5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-4-oxo-3,4-dihydropyrido[4,3-d]pyrimidin-7-yl)-2-morpholinyl)benzonitrile,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(3-(trifluoromethyl)phenyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-(3-(trifluoromethyl)phenyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(2-(5-phenyl-1,2,4-oxadiazol-3-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(2-(2-(trifluoromethyl)-4-pyridinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-(2-(2,2,2-trifluoroethoxy)-4-pyridinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(2-(2,2,2-trifluoroethoxy)-4-pyridinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-(3-(trifluoromethoxy)phenyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(3-(trifluoromethoxy)phenyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(2-(1-methyl-1H-pyrazol-4-yl)-1-piperidinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((3R)-3-(1-methyl-1H-pyrazol-4-yl)-1-piperidinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-(3,4-dihydro-2,6-naphthyridin-2(1H)-yl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-(3,4-dihydro-2,7-naphthyridin-2(1H)-yl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(1-methyl-1,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridin-6-yl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(3-(1,3-oxazol-5-yl)-1-piperidinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(3-(5-oxo-3-pyrrolidinyl)-1-piperidinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((3S)-3-(1H-pyrazol-4-yl)-1-piperidinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((3R)-3-(1H-pyrazol-4-yl)-1-piperidinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-(3-(dimethylamino)-1-piperidinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
7-(3-(1-azetidinyl)-1-piperidinyl)-5-(4-chloro-2-fluorophenyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((3R)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-1-piperidinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((3S)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-1-piperidinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((3S)-3-(4-pyridinyl)-1-piperidinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((3R)-3-(4-pyridinyl)-1-piperidinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
7-(8-chloro-3,4-dihydro-2,7-naphthyridin-2(1H)-yl)-5-(4-chloro-2-fluorophenyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5'-(4-chloro-2-fluorophenyl)-4-methoxy-2',3'-dimethyl-7,8-dihydro-5H-[6,7'-bipyrido[4,3-d]pyrimidin]-4'(3'H)-one,
5-(4-chloro-2-fluorophenyl)-7-((3R)-4,4-difluoro-3-(1-methyl-1H-pyrazol-4-yl)-1-piperidinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((3S)-4,4-difluoro-3-(1-methyl-1H-pyrazol-4-yl)-1-piperidinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(3-(trifluoromethyl)-1-pyrrolidinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-(3-(difluoromethyl)-1-pyrrolidinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(3-(3-pyridinyl)-1-pyrrolidinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(1-(2-propanyl)-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(1-cyclobutyl-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(1-(3-oxetanyl)-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(1-(2-methoxyethyl)-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(1-(2-fluoroethyl)-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(1-(1-fluoroethyl)-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(1-(1-fluoro-2-hydroxyethyl)-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(1-(3,3-difluorocyclobutyl)-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(1-(2-(dimethylamino)ethyl)-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(1-(1,3-difluoro-2-propanyl)-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
2-methyl-2-propanyl 3-(4-((2S)-4-(5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-4-oxo-3,4-dihydropyrido[4,3-d]pyrimidin-7-yl)-2-morpholinyl)-1H-pyrazol-1-yl)-1-azetidinecarboxylate,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(1-(1,2-difluoroethyl)-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(1-cyclopropyl-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(1-ethenyl-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(1-(1-methyl-3-azetidinyl)-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(6-methyl-3-pyridinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-(6-methyl-3-pyridinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(1-(trifluoromethyl)-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2-cyclopropyl-3-methyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-3-methyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)-2-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-3-ethyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)-2-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2-methyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-3-ethyl-2-methyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-3-ethyl-2-methyl-7-((2S)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-3-ethyl-2-methyl-7-((2R
)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-3-ethyl-2-methyl-7-((2S)-2-(2-methyl-4-pyridinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(2,4-difluorophenyl)-3-ethyl-2-methyl-7-((2S)-2-(2-methyl-4-pyridinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
7-((2S)-2-(1-cyclopropyl-1H-pyrazol-4-yl)-4-morpholinyl)-5-(2,4-difluorophenyl)-3-ethyl-2-methylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2-methyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)-3-propylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(5-chloro-3-fluoro-2-pyridinyl)-2-methyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)-3-propylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2-methyl-7-((2S)-2-(1-methyl-1H-pyrazol-5-yl)-4-morpholinyl)-3-propylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2-methyl-7-((2R)-2-(1-methyl-1H-pyrazol-5-yl)-4-morpholinyl)-3-propylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R)-2-(difluoromethyl)-4-morpholinyl)-2-methyl-3-propylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2-methyl-7-((2S)-2-phenyl-4-morpholinyl)-3-propylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-3-methyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-cyclohexyl-2,3-dimethyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-cyclopentyl-2,3-dimethyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R,4R)-2-(1-methyl-1H-pyrazol-4-yl)tetrahydro-2H-pyran-4-yl)pyrido[4,3-d]pyrimidin-4(3H)-one and 5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S,4S)-2-(1-methyl-1H-pyrazol-4-yl)tetrahydro-2H-pyran-4-yl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R,4S)-2-(1-methyl-1H-pyrazol-4-yl)tetrahydro-2H-pyran-4-yl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S,4R)-2-(1-methyl-1H-pyrazol-4-yl)tetrahydro-2H-pyran-4-yl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(6-(1-methyl-1H-pyrazol-4-yl)-3,6-dihydro-2H-pyran-4-yl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R,4S)-2-(1-cyclopropyl-1H-pyrazol-4-yl)tetrahydro-2H-pyran-4-yl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S,4R)-2-(1-cyclopropyl-1H-pyrazol-4-yl)tetrahydro-2H-pyran-4-yl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
(2R,4S)-4-(5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-4-oxo-3,4-dihydropyrido[4,3-d]pyrimidin-7-yl)tetrahydro-2H-pyran-2-carboxylate and (2S,4R)-4-(5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-4-oxo-3,4-dihydropyrido[4,3-d]pyrimidin-7-yl)tetrahydro-2H-pyran-2-carboxylate,
(2S,4S)-4-(5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-4-oxo-3,4-dihydropyrido[4,3-d]pyrimidin-7-yl)tetrahydro-2H-pyran-2-carboxylate and (2R,4R)-4-(5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-4-oxo-3,4-dihydropyrido[4,3-d]pyrimidin-7-yl)tetrahydro-2H-pyran-2-carboxylate,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R,4S)-2-(2-methyl-4-pyridinyl)tetrahydro-2H-pyran-4-yl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S,4R)-2-(2-methyl-4-pyridinyl)tetrahydro-2H-pyran-4-yl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(2-(6-methylpyridin-3-yl)tetrahydro-2H-pyran-4-yl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R,4S)-2-(2-methoxy-4-pyridinyl)tetrahydro-2H-pyran-4-yl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S,4R)-2-(2-methoxy-4-pyridinyl)tetrahydro-2H-pyran-4-yl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R,4R)-2-(2-methoxy-4-pyridinyl)tetrahydro-2H-pyran-4-yl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S,4S)-2-(2-methoxy-4-pyridinyl)tetrahydro-2H-pyran-4-yl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R,4R)-2-(3-pyridinyl)tetrahydro-2H-pyran-4-yl)pyrido[4,3-d]pyrimidin-4(3H)-one and 5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S,4S)-2-(3-pyridinyl)tetrahydro-2H-pyran-4-yl)pyrido[4,3-d]pyrimidin-4(3H)-one,
2. The compound according to aspect 1, which is 5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R,4S)-2-(3-pyridinyl)tetrahydro-2H-pyran-4-yl)pyrido[4,3-d]pyrimidin-4(3H)-one, or 5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S,4R)-2-(3-pyridinyl)tetrahydro-2H-pyran-4-yl)pyrido[4,3-d]pyrimidin-4(3H)-one, or a tautomer thereof, or a pharma- ceutically acceptable salt of said compound or said tautomer.
[Aspect 35]
The compound is
[Aspect 36]
The compound is
[Aspect 37]
The compound is
[Aspect 38]
The compound is
[Aspect 39]
The compound is
[Aspect 40]
The compound is
[Aspect 41]
The compound is
[Aspect 42]
The compound is
[Aspect 43]
A pharmaceutical composition comprising a compound according to any one of aspects 1 to 42, or a tautomer thereof, or a pharma- ceutically acceptable salt of said compound or said tautomer, and a pharma- ceutically acceptable excipient.
[Aspect 44]
A compound or a tautomer thereof according to any one of aspects 1 to 42, or a pharma- ceutically acceptable salt of said compound or said tautomer, or a pharmaceutical composition according to aspect 43, for use as a medicament.
[Aspect 45]
A compound or a tautomer thereof according to any one of aspects 1 to 42, or a pharma- ceutically acceptable salt of said compound or said tautomer, or a pharmaceutical composition according to aspect 43, for use in the treatment or prevention of a condition associated with loss of function of human TREM2.
[Aspect 46]
A compound or a tautomer thereof according to any one of aspects 1 to 42, or a pharma- ceutically acceptable salt of said compound or said tautomer, or a pharmaceutical composition according to aspect 43, for use in the treatment or prevention of Parkinson's disease, rheumatoid arthritis, Alzheimer's disease, Nasu-Hakola disease, frontotemporal dementia, multiple sclerosis, prion disease, or stroke.
[Aspect 47]
Use of a compound according to any one of aspects 1 to 42 or a tautomer thereof, or a pharma- ceutically acceptable salt of said compound or said tautomer, or a pharmaceutical composition according to aspect 43, in the preparation of a medicament for treating or preventing a condition associated with loss of function of human TREM2.
[Aspect 48]
Use of a compound or a tautomer thereof according to any one of aspects 1 to 42, or a pharma- ceutically acceptable salt of said compound or said tautomer, or a pharmaceutical composition according to aspect 43, in the preparation of a medicament for the treatment or prevention of Parkinson's disease, rheumatoid arthritis, Alzheimer's disease, Nasu-Hakola disease, frontotemporal dementia, multiple sclerosis, prion disease, or stroke.
[Aspect 49]
A method of treating or preventing a condition associated with loss of function of human TREM2 in a subject in need thereof, comprising administering to said subject a therapeutically effective amount of a compound according to any one of aspects 1-42, or a tautomer thereof, or a pharma- ceutically acceptable salt of said compound or said tautomer.
[Aspect 50]
43. A method of treating or preventing Parkinson's disease, rheumatoid arthritis, Alzheimer's disease, Nasu-Hakola disease, frontotemporal dementia, multiple sclerosis, prion disease, or stroke in a subject in need thereof, comprising administering to said subject a therapeutically effective amount of a compound according to any one of aspects 1 to 42, or a tautomer thereof, or a pharmacologic acceptable salt of said compound or said tautomer.
Claims (19)
X1が、(1)CH又はNであり、bが、単結合であるか、又は(2)C及びbが、二重結合であり、
X2が、CH2、CHF、CF2、O、又はNHであり、
任意に、R5が、存在せず、X2CR6基が、5又は6員ヘテロアリールを形成し、前記5員ヘテロアリールが、N、O、及びSから選択される1つのみの環原子、及び任意に、1つのみの更なるN環原子を含み、前記6員ヘテロアリールが、1つのみ又は2つのみのN環原子を含み、前記5又は6員ヘテロアリールが、ハロゲン、C1~3アルキル、又はC1~3アルコキシで任意に置換され、
各発生におけるX3が、独立して、CH又はNであり、
R1が、H、C1~6アルキル、C1~6ハロアルキル、又はC3~6シクロアルキルであり、
R2が、H、C1~3アルキル、C1~3ハロアルキル、又はC3~6シクロアルキルであり、
R3が、H又はC1~3アルキルであり、
R4が、H又はC1~3アルキルであり、
R5が、H又はC1~3アルキルであり、
R6が、C2~6アルキル、C1~6ハロアルキル、ジC1~3アルキルアミノ、-C(=O)O(C1~6アルキル)、C3~6シクロアルキル、C3~6ヘテロシクロアルキル、フェニル、5員ヘテロアリール、又は6員ヘテロアリールであり、
(1)C3~6シクロアルキル又はC3~6ヘテロシクロアルキルが、C=Oで任意に置換され、
(2)前記フェニル、5員ヘテロアリール、又は6員ヘテロアリール基が、独立して、ハロゲン、C1~6アルキル、C1~6ハロアルキル、C1~6アルコキシ、C1~6ハロアルコキシ、-(C1~3アルキル)O(C1~3アルキル)、-(C1~3アルキル)NH2、-(C1~3アルキル)NH(C1~3アルキル)、-(C1~3アルキル)N[(C1~3アルキル)(C1~3アルキル)]、-CN、C2~4アルケニル、C3~6シクロアルキル、フェニル、及びC3~6ヘテロシクロアルキルから選択される1~3個の置換基で任意に置換され、
前記サブセクション(2)のC1~6アルキル及びC1~6ハロアルキルが、OHで任意に置換され、
前記サブセクション(2)のC3~6ヘテロシクロアルキルが、ハロゲン、C1~3アルキル、及び-C(=O)O(C1~6アルキル)から選択される1~3個の置換基で任意に置換され、
R7が、C5~6シクロアルキル、C5~8スピロアルキル、C5~8トリシクロアル
キル、フェニル、又は6員ヘテロアリールであり、R7が、更に、独立して、ハロゲン、C1~3アルキル、及びC1~3ハロアルキルから選択される1~4個の置換基で任意に置換され、
nが、0又は1であるが、但し、X1がNであり、nが0であるときに、X2がNH又はOではないことを条件とする、式Iの化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。 Compounds of Formula I
X1 is (1) CH or N, and b is a single bond, or (2) C and b are double bonds;
X2 is CH2 , CHF, CF2 , O, or NH;
Optionally, R 5 is absent and the X 2 CR 6 groups form a 5- or 6-membered heteroaryl, said 5-membered heteroaryl containing only one ring atom selected from N, O and S, and optionally only one further N ring atom, said 6-membered heteroaryl containing only one or only two N ring atoms, said 5- or 6-membered heteroaryl being optionally substituted with halogen, C 1-3 alkyl, or C 1-3 alkoxy;
X3 at each occurrence is independently CH or N;
R 1 is H, C 1-6 alkyl, C 1-6 haloalkyl, or C 3-6 cycloalkyl;
R2 is H, C1-3 alkyl, C1-3 haloalkyl, or C3-6 cycloalkyl;
R3 is H or C1-3 alkyl;
R 4 is H or C 1-3 alkyl;
R 5 is H or C 1-3 alkyl;
R 6 is C 2-6 alkyl, C 1-6 haloalkyl, diC 1-3 alkylamino, -C(=O)O(C 1-6 alkyl), C 3-6 cycloalkyl, C 3-6 heterocycloalkyl, phenyl, 5-membered heteroaryl, or 6-membered heteroaryl;
(1) C 3-6 cycloalkyl or C 3-6 heterocycloalkyl is optionally substituted with C═O;
(2) the phenyl, 5-membered heteroaryl, or 6-membered heteroaryl group is optionally substituted with 1 to 3 substituents independently selected from halogen, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, -( C1-3 alkyl)O(C1-3 alkyl ), -( C1-3 alkyl) NH2 , -( C1-3 alkyl)NH( C1-3 alkyl), -( C1-3 alkyl)N[( C1-3 alkyl)( C1-3 alkyl)], -CN, C2-4 alkenyl, C3-6 cycloalkyl, phenyl, and C3-6 heterocycloalkyl;
the C 1-6 alkyl and C 1-6 haloalkyl of subsection (2) are optionally substituted with OH;
the C3-6 heterocycloalkyl of subsection (2) is optionally substituted with 1 to 3 substituents selected from halogen, C1-3 alkyl, and -C(=O)O( C1-6 alkyl);
R 7 is a C 5-6 cycloalkyl, a C 5-8 spiroalkyl, a C 5-8 tricycloalkyl, a phenyl, or a 6-membered heteroaryl, R 7 is optionally further substituted with 1 to 4 substituents independently selected from halogen, C 1-3 alkyl, and C 1-3 haloalkyl;
A compound of formula I, or a tautomer thereof, wherein n is 0 or 1, with the proviso that when X1 is N and n is 0, then X2 is not NH or O; or a pharma- ceutically acceptable salt of said compound or said tautomer.
好ましくは、X 2 が、Oである、
請求項1または請求項2に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。 X2 is CH2 , CF2 , or O;
Preferably, X2 is O.
3. A compound according to claim 1 or claim 2 , or a tautomer thereof, or a pharma- ceutically acceptable salt of said compound or said tautomer.
X 3 が、Nである、
請求項1~4のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。 X3 is CH , or
X3 is N;
5. A compound according to any one of claims 1 to 4, or a tautomer thereof, or a pharma- ceutically acceptable salt of said compound or said tautomer.
好ましくは、R 1 が、メチルである、
請求項1~5のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。 R 1 is methyl, ethyl, propyl, -CH 2 CF 3 , cyclopropyl, or cyclohexyl;
Preferably, R 1 is methyl.
6. A compound according to any one of claims 1 to 5 , or a tautomer thereof, or a pharma- ceutically acceptable salt of said compound or said tautomer.
好ましくは、R 2 が、メチルである、
請求項1~6のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。 R2 is H, methyl, trifluoromethyl, or cyclopropyl;
Preferably, R2 is methyl.
7. A compound according to any one of claims 1 to 6 , or a tautomer thereof, or a pharma- ceutically acceptable salt of said compound or said tautomer.
好ましくは、R 3 が、Hである、
請求項1~7のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。 R3 is H or methyl;
Preferably, R3 is H.
8. A compound according to any one of claims 1 to 7 , or a tautomer thereof, or a pharma- ceutically acceptable salt of said compound or said tautomer.
好ましくは、R 4 が、Hである、
請求項1~8のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。 R4 is H or methyl;
Preferably, R4 is H.
9. A compound according to any one of claims 1 to 8 , or a tautomer thereof, or a pharma- ceutically acceptable salt of said compound or said tautomer.
好ましくは、R 5 が、Hである、
請求項1~9のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。 R5 is H or methyl;
Preferably, R5 is H.
10. The compound according to any one of claims 1 to 9 , or a tautomer thereof, or a pharma- ceutically acceptable salt of said compound or said tautomer.
あるいは、
R 6 が、ジフルオロメチル、トリフルオロメチル、-CH 2 CF 3 、ジメチルアミノ、-C(=O)OCH 2 CH 3 、シクロプロピル、シクロブチル、オキセタン-2-イル、アゼチジン-1-イル、テトラヒドロフラン-3-イル、
好ましくは、R 6 が、
請求項1~10のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。 R 6 is difluoromethyl, trifluoromethyl, -CH 2 CF 3 , dimethylamino, -C(=O)OCH 2 CH 3 , optionally substituted cyclopropyl, optionally substituted cyclobutyl, optionally substituted oxetanyl, optionally substituted azetidinyl, optionally substituted tetrahydrofuranyl, optionally substituted pyrrolidinyl, optionally substituted phenyl, optionally substituted pyrazolyl, optionally substituted imidazolyl, optionally substituted 1,3-oxazolyl, optionally substituted 1,2,4-oxadiazolyl, optionally substituted 1,3,4-oxadiazolyl, optionally substituted thiophenyl, optionally substituted thiazolyl, optionally substituted pyridinyl, optionally substituted pyridazinyl, or optionally substituted pyrimidinyl.
or,
R 6 is difluoromethyl, trifluoromethyl, —CH 2 CF 3 , dimethylamino, —C(═O)OCH 2 CH 3 , cyclopropyl, cyclobutyl, oxetan-2-yl, azetidin-1-yl, tetrahydrofuran-3-yl,
Preferably, R6 is
11. A compound according to any one of claims 1 to 10, or a tautomer thereof, or a pharma- ceutically acceptable salt of said compound or said tautomer.
あるいは、
R 7 が、任意に置換されたC 5~6 シクロアルキル、任意に置換されたフェニル、又は任意に置換されたピリジニルである、
あるいは、
R 7 が、
好ましくは、R 7 が、
請求項1~11のいずれか一項に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。 R 7 is an optionally substituted C 5-6 cycloalkyl, an optionally substituted phenyl, or an optionally substituted 6-membered heteroaryl;
or,
R 7 is optionally substituted C 5-6 cycloalkyl, optionally substituted phenyl, or optionally substituted pyridinyl;
or,
R7 is
Preferably, R7 is
12. A compound according to any one of claims 1 to 11, or a tautomer thereof, or a pharma- ceutically acceptable salt of said compound or said tautomer.
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)-4(3H)-キナゾリノン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)-4(3H)-キナゾリノン、
5-(4-クロロフェニル)-2,3-ジメチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロフェニル)-2,3-ジメチル-7-((2R)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-3-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(2,4-ジフルオロフェニル)-2,3-ジメチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
2,3-ジメチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)-5-(2,3,4-トリフルオロフェニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
2,3-ジメチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)-5-(2,4,5-トリフルオロフェニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2,5-ジフルオロフェニル)-2,3-ジメチル-7-((2S
)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(2-フルオロ-4-メチルフェニル)-2,3-ジメチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(2-フルオロ-4-(トリフルオロメチル)フェニル)-2,3-ジメチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2,3-ジフルオロフェニル)-2,3-ジメチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(5-クロロ-3-フルオロ-2-ピリジニル)-2,3-ジメチル-7-(2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)-4(3H)-キナゾリノン、
2,3-ジメチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)-5-(6-(トリフルオロメチル)-3-ピリジニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-3-シクロヘキシル-2-メチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2-メチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)-3-(2,2,2-トリフルオロエチル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-3-シクロプロピル-2-メチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
±5-(5-クロロ-3-フルオロ-2-ピリジニル)-2-メチル-7-(2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)-3-プロピルピリド-[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(1-エチル-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R)-2-(1-エチル-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S,5R)-5-メチル-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R,5R)-5-メチル-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R,6R)-2-メチル-6-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R,6S)-2-メチル-6-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S,6R)-2-メチル-6-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S,6S)-2-メチル-6-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(2-メチル-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-シクロプロピル-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2-シクロブチル-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S,6R)-2-シクロプロピル-6-メチル-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S,6S)-2-シクロプロピル-6-メチル-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R,6R)-2-シクロプロピル-6-メチル-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R,6S)-2-シクロプロピル-6-メチル-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-((2R)-2-オキセタニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-((2S)-2-オキセタニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-((2S)-2-オキセタニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-((2R)-2-オキセタニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-((3S)-テトラヒドロ-3-フラニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-((3S)-テトラヒドロ-3-フラニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-((3R)-テトラヒドロ-3-フラニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-((3R)-テトラヒドロ-3-フラニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(3-ピリジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-(3-ピリジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-(4-ピリジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(4-ピリジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(2-(4-ピリダニジル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(2-(5-ピリミジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(2-(1-メチル-1H-ピラゾール-5-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(2-(2,2,2-トリフルオロエチル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-(チオフェン-3-イル)モルホリノ)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(3-チオフェニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-(5-メチル-1,2,4-オキサジアゾール-3-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(5-メチル-1,2,4-オキサジアゾール-3-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(5-メチル-1,3,4-オキサジアゾール-2-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-(5-メチル-1,3,4-オキサジアゾール-2-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(2-(6-メチル-3-ピリジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(2-メチル-4-ピリジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-(2-メチル-4-ピリジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジ
ン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(2-(2-メチル-4-ピリミジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-(2-メチル-5-ピリミジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(2-メチル-5-ピリミジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R)-2-(1,5-ジメチル-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(1,5-ジメチル-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-(2-(1,3-ジメチル-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-(2-(5-フルオロ-3-ピリジニル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-(2-(5-エチル-1,3,4-オキサジアゾール-2-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S,6S)-2-メチル-6-(3-チオフェニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S,6R)-2-メチル-6-(3-チオフェニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R,6S)-2-メチル-6-(3-チオフェニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R,6R)-2-メチル-6-(3-チオフェニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(2-(4-メチル-1,3-チアゾール-2-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R)-2-(2,6-ジメチル-4-ピリジニル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(2,6-ジメチル-4-ピリジニル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(4-メトキシフェニル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R)-2-(4-メトキシフ
ェニル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(3-メトキシフェニル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R)-2-(3-メトキシフェニル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(2-メトキシ-4-ピリジニル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R)-2-(2-メトキシ-4-ピリジニル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R)-2-(5-シクロプロピル-1,2,4-オキサジアゾール-3-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(5-シクロプロピル-1,2,4-オキサジアゾール-3-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R)-2-(4-クロロフェニル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(4-クロロフェニル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R)-2-(2-クロロ-4-ピリジニル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(2-クロロ-4-ピリジニル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
4-(4-(5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-4-オキソ-3,4-ジヒドロピリド[4,3-d]ピリミジン-7-イル)-2-モルホリニル)ベンゾニトリル、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(3-(トリフルオロメチル)フェニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-(3-(トリフルオロメチル)フェニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(2-(5-フェニル-1,2,4-オキサジアゾール-3-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(2-(2-(トリフルオロメチル)-4-ピリジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-(2-(2,2,2-トリフルオロエトキシ)-4-ピリジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(2-(2,2,2-トリフルオロエトキシ)-4-ピリジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-(3-(トリフルオロメトキシ)フェニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(3-(トリフルオロメトキシ)フェニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(2-(1-メチル-1H-ピラゾール-4-イル)-1-ピペリジニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((3R)-3-(1-メチル-1H-ピラゾール-4-イル)-1-ピペリジニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-(3,4-ジヒドロ-2,6-ナフチリジン-2(1H)-イル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-(3,4-ジヒドロ-2,7-ナフチリジン-2(1H)-イル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(1-メチル-1,4,5,7-テトラヒドロ-6H-ピラゾロ[3,4-c]ピリジン-6-イル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(3-(1,3-オキサゾール-5-イル)-1-ピペリジニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(3-(5-オキソ-3-ピロリジニル)-1-ピペリジニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((3S)-3-(1H-ピラゾール-4-イル)-1-ピペリジニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((3R)-3-(1H-ピラゾール-4-イル)-1-ピペリジニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-(3-(ジメチルアミノ)-1-ピペリジニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
7-(3-(1-アゼチジニル)-1-ピペリジニル)-5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((3R)-3-(3-メチル-1,2,4-オキサジアゾール-5-イル)-1-ピペリジニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((3S)-3-(3-メチル-1,2,4-オキサジアゾール-5-イル)-1-ピペリジニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((3S)-3-(4-ピリジニル)-1-ピペリジニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((3R)-3-(4-ピリジニル)-1-ピペリジニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
7-(8-クロロ-3,4-ジヒドロ-2,7-ナフチリジン-2(1H)-イル)-5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5’-(4-クロロ-2-フルオロフェニル)-4-メトキシ-2’,3’-ジメチル-7,8-ジヒドロ-5H-[6,7’-ビピリド[4,3-d]ピリミジン]-4’(3’H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((3R)-4,4-ジフルオロ-3-(1-メチル-1H-ピラゾール-4-イル)-1-ピペリジニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((3S)-4,4-ジフルオロ-3-(1-メチル-1H-ピラゾール-4-イル)-1-ピペリジニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(3-(トリフルオロメチル)-1-ピロリジニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-(3-(ジフルオロメチル)-1-ピロリジニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(3-(3-ピリジニル)-1-ピロリジニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(1-(2-プロパニル)-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(1-シクロブチル-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(1-(3-オキセタニル)-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(1-(2,2,2-トリフルオロエチル)-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(1-(2-メトキシエチル)-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(1-(2-フルオロエチル)-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(1-(1-フルオロエチル)-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(1-(1-フルオロ-2-ヒドロキシエチル)-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(1-(3,3-ジフルオロシクロブチル)-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(1-(2-(ジメチルアミノ)エチル)-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(1-(1,3-ジフルオロ-2-プロパニル)-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
2-メチル-2-プロパニル3-(4-((2S)-4-(5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-4-オキソ-3,4-ジヒドロピリド[4,3-d]ピリミジン-7-イル)-2-モルホリニル)-1H-ピラゾール-1-イル)-1-アゼチジンカルボキシレート、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(1-(1,2-ジフルオロエチル)-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(1-シクロプロピル-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S)-2-(1-エテニル-1H-ピラゾール-4-イル)-4-モルホリニル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(1-(1-メチル-3-アゼチジニル)-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(6-メチル-3-ピリジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R)-2-(6-メチル-3-ピリジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S)-2-(1-(トリフルオロメチル)-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2-シクロプロピル-3-メチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-3-メチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)-2-(トリフルオロメチル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-3-エチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)-2-(トリフルオロメチル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2-メチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-3-エチル-2-メチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-3-エチル-2-メチル-7-((2S)-2-(5-メチル-1,2,4-オキサジアゾール-3-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-3-エチル-2-メチル-7-((2R
)-2-(5-メチル-1,2,4-オキサジアゾール-3-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-3-エチル-2-メチル-7-((2S)-2-(2-メチル-4-ピリジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(2,4-ジフルオロフェニル)-3-エチル-2-メチル-7-((2S)-2-(2-メチル-4-ピリジニル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
7-((2S)-2-(1-シクロプロピル-1H-ピラゾール-4-イル)-4-モルホリニル)-5-(2,4-ジフルオロフェニル)-3-エチル-2-メチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2-メチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)-3-プロピルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(5-クロロ-3-フルオロ-2-ピリジニル)-2-メチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)-3-プロピルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2-メチル-7-((2S)-2-(1-メチル-1H-ピラゾール-5-イル)-4-モルホリニル)-3-プロピルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2-メチル-7-((2R)-2-(1-メチル-1H-ピラゾール-5-イル)-4-モルホリニル)-3-プロピルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R)-2-(ジフルオロメチル)-4-モルホリニル)-2-メチル-3-プロピルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2-メチル-7-((2S)-2-フェニル-4-モルホリニル)-3-プロピルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-3-メチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-シクロヘキシル-2,3-ジメチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-シクロペンチル-2,3-ジメチル-7-((2S)-2-(1-メチル-1H-ピラゾール-4-イル)-4-モルホリニル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R,4R)-2-(1-メチル-1H-ピラゾール-4-イル)テトラヒドロ-2H-ピラン-4-イル)ピリド[4,3-d]ピリミジン-4(3H)-オン及び5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S,4S)-2-(1-メチル-1H-ピラゾール-4-イル)テトラヒドロ-2H-ピラン-4-イル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R,4S)-2-(1-メチル-1H-ピラゾール-4-イル)テトラヒドロ-2H-ピラン-4-イル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S,4R)-2-(1-メチル-1H-ピラゾール-4-イル)テトラヒドロ-2H-ピラン-4-イル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(6-(1-メチル-1H-ピラゾール-4-イル)-3,6-ジヒドロ-2H-ピラン-4-イル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R,4S)-2-(1-シクロプロピル-1H-ピラゾール-4-イル)テトラヒドロ-2H-ピラン-4-イル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S,4R)-2-(1-シクロプロピル-1H-ピラゾール-4-イル)テトラヒドロ-2H-ピラン-4-イル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
(2R,4S)-4-(5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-4-オキソ-3,4-ジヒドロピリド[4,3-d]ピリミジン-7-イル)テトラヒドロ-2H-ピラン-2-カルボン酸エチル及び(2S,4R)-4-(5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-4-オキソ-3,4-ジヒドロピリド[4,3-d]ピリミジン-7-イル)テトラヒドロ-2H-ピラン-2-カルボン酸エチル、
(2S,4S)-4-(5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-4-オキソ-3,4-ジヒドロピリド[4,3-d]ピリミジン-7-イル)テトラヒドロ-2H-ピラン-2-カルボン酸エチル及び(2R,4R)-4-(5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-4-オキソ-3,4-ジヒドロピリド[4,3-d]ピリミジン-7-イル)テトラヒドロ-2H-ピラン-2-カルボン酸エチル、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R,4S)-2-(2-メチル-4-ピリジニル)テトラヒドロ-2H-ピラン-4-イル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S,4R)-2-(2-メチル-4-ピリジニル)テトラヒドロ-2H-ピラン-4-イル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-(2-(6-メチルピリジン-3-イル)テトラヒドロ-2H-ピラン-4-イル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R,4S)-2-(2-メトキシ-4-ピリジニル)テトラヒドロ-2H-ピラン-4-イル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S,4R)-2-(2-メトキシ-4-ピリジニル)テトラヒドロ-2H-ピラン-4-イル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2R,4R)-2-(2-メトキシ-4-ピリジニル)テトラヒドロ-2H-ピラン-4-イル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-7-((2S,4S)-2-(2-メトキシ-4-ピリジニル)テトラヒドロ-2H-ピラン-4-イル)-2,3-ジメチルピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R,4R)-2-(3-ピリジニル)テトラヒドロ-2H-ピラン-4-イル)ピリド[4,3-d]ピリミジン-4(3H)-オン及び5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S,4S)-2-(3-ピリジニル)テトラヒドロ-2H-ピラン-4-イル)ピリド[4,3-d]ピリミジン-4(3H)-オン、
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2R,4S)-2-(3-ピリジニル)テトラヒドロ-2H-ピラン-4-イル)ピリド[4,3-d]ピリミジン-4(3H)-オン、又は
5-(4-クロロ-2-フルオロフェニル)-2,3-ジメチル-7-((2S,4R)-2-(3-ピリジニル)テトラヒドロ-2H-ピラン-4-イル)ピリド[4,3-d]ピリミジン-4(3H)-オンである、請求項1に記載の化合物若しくはその互変異性体、又は前記化合物若しくは前記互変異性体の薬学的に許容される塩。 The compound is
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)-4(3H)-quinazolinone,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)-4(3H)-quinazolinone,
5-(4-chlorophenyl)-2,3-dimethyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chlorophenyl)-2,3-dimethyl-7-((2R)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-3-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(2,4-difluorophenyl)-2,3-dimethyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
2,3-dimethyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)-5-(2,3,4-trifluorophenyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
2,3-dimethyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)-5-(2,4,5-trifluorophenyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2,5-difluorophenyl)-2,3-dimethyl-7-((2S
)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(2-fluoro-4-methylphenyl)-2,3-dimethyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(2-fluoro-4-(trifluoromethyl)phenyl)-2,3-dimethyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2,3-difluorophenyl)-2,3-dimethyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(5-chloro-3-fluoro-2-pyridinyl)-2,3-dimethyl-7-(2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)-4(3H)-quinazolinone,
2,3-dimethyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)-5-(6-(trifluoromethyl)-3-pyridinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-3-cyclohexyl-2-methyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2-methyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)-3-(2,2,2-trifluoroethyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-3-cyclopropyl-2-methyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
±5-(5-chloro-3-fluoro-2-pyridinyl)-2-methyl-7-(2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)-3-propylpyrido-[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(1-ethyl-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R)-2-(1-ethyl-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S,5R)-5-methyl-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R,5R)-5-methyl-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R,6R)-2-methyl-6-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R,6S)-2-methyl-6-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S,6R)-2-methyl-6-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S,6S)-2-methyl-6-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(2-methyl-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-cyclopropyl-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2-cyclobutyl-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S,6R)-2-cyclopropyl-6-methyl-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S,6S)-2-cyclopropyl-6-methyl-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R,6R)-2-cyclopropyl-6-methyl-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R,6S)-2-cyclopropyl-6-methyl-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-((2R)-2-oxetanyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-((2S)-2-oxetanyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-((2S)-2-oxetanyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-((2R)-2-oxetanyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-((3S)-tetrahydro-3-furanyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-((3S)-tetrahydro-3-furanyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-((3R)-tetrahydro-3-furanyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-((3R)-tetrahydro-3-furanyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(3-pyridinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-(3-pyridinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-(4-pyridinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(4-pyridinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(2-(4-pyridanidyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(2-(5-pyrimidinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(2-(1-methyl-1H-pyrazol-5-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(2-(2,2,2-trifluoroethyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-(thiophen-3-yl)morpholino)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(3-thiophenyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(5-methyl-1,3,4-oxadiazol-2-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-(5-methyl-1,3,4-oxadiazol-2-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(2-(6-methyl-3-pyridinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(2-methyl-4-pyridinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-(2-methyl-4-pyridinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(2-(2-methyl-4-pyrimidinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-(2-methyl-5-pyrimidinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(2-methyl-5-pyrimidinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R)-2-(1,5-dimethyl-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(1,5-dimethyl-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-(2-(1,3-dimethyl-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-(2-(5-fluoro-3-pyridinyl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-(2-(5-ethyl-1,3,4-oxadiazol-2-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S,6S)-2-methyl-6-(3-thiophenyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S,6R)-2-methyl-6-(3-thiophenyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R,6S)-2-methyl-6-(3-thiophenyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R,6R)-2-methyl-6-(3-thiophenyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(2-(4-methyl-1,3-thiazol-2-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R)-2-(2,6-dimethyl-4-pyridinyl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(2,6-dimethyl-4-pyridinyl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(4-methoxyphenyl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R)-2-(4-methoxyphenyl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(3-methoxyphenyl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R)-2-(3-methoxyphenyl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(2-methoxy-4-pyridinyl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R)-2-(2-methoxy-4-pyridinyl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R)-2-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R)-2-(4-chlorophenyl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(4-chlorophenyl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R)-2-(2-chloro-4-pyridinyl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(2-chloro-4-pyridinyl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
4-(4-(5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-4-oxo-3,4-dihydropyrido[4,3-d]pyrimidin-7-yl)-2-morpholinyl)benzonitrile,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(3-(trifluoromethyl)phenyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-(3-(trifluoromethyl)phenyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(2-(5-phenyl-1,2,4-oxadiazol-3-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(2-(2-(trifluoromethyl)-4-pyridinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-(2-(2,2,2-trifluoroethoxy)-4-pyridinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(2-(2,2,2-trifluoroethoxy)-4-pyridinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-(3-(trifluoromethoxy)phenyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(3-(trifluoromethoxy)phenyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(2-(1-methyl-1H-pyrazol-4-yl)-1-piperidinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((3R)-3-(1-methyl-1H-pyrazol-4-yl)-1-piperidinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-(3,4-dihydro-2,6-naphthyridin-2(1H)-yl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-(3,4-dihydro-2,7-naphthyridin-2(1H)-yl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(1-methyl-1,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridin-6-yl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(3-(1,3-oxazol-5-yl)-1-piperidinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(3-(5-oxo-3-pyrrolidinyl)-1-piperidinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((3S)-3-(1H-pyrazol-4-yl)-1-piperidinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((3R)-3-(1H-pyrazol-4-yl)-1-piperidinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-(3-(dimethylamino)-1-piperidinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
7-(3-(1-azetidinyl)-1-piperidinyl)-5-(4-chloro-2-fluorophenyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((3R)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-1-piperidinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((3S)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-1-piperidinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((3S)-3-(4-pyridinyl)-1-piperidinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((3R)-3-(4-pyridinyl)-1-piperidinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
7-(8-chloro-3,4-dihydro-2,7-naphthyridin-2(1H)-yl)-5-(4-chloro-2-fluorophenyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5'-(4-chloro-2-fluorophenyl)-4-methoxy-2',3'-dimethyl-7,8-dihydro-5H-[6,7'-bipyrido[4,3-d]pyrimidin]-4'(3'H)-one,
5-(4-chloro-2-fluorophenyl)-7-((3R)-4,4-difluoro-3-(1-methyl-1H-pyrazol-4-yl)-1-piperidinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((3S)-4,4-difluoro-3-(1-methyl-1H-pyrazol-4-yl)-1-piperidinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(3-(trifluoromethyl)-1-pyrrolidinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-(3-(difluoromethyl)-1-pyrrolidinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(3-(3-pyridinyl)-1-pyrrolidinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(1-(2-propanyl)-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(1-cyclobutyl-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(1-(3-oxetanyl)-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(1-(2-methoxyethyl)-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(1-(2-fluoroethyl)-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(1-(1-fluoroethyl)-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(1-(1-fluoro-2-hydroxyethyl)-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(1-(3,3-difluorocyclobutyl)-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(1-(2-(dimethylamino)ethyl)-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(1-(1,3-difluoro-2-propanyl)-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
2-methyl-2-propanyl 3-(4-((2S)-4-(5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-4-oxo-3,4-dihydropyrido[4,3-d]pyrimidin-7-yl)-2-morpholinyl)-1H-pyrazol-1-yl)-1-azetidinecarboxylate,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(1-(1,2-difluoroethyl)-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(1-cyclopropyl-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S)-2-(1-ethenyl-1H-pyrazol-4-yl)-4-morpholinyl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(1-(1-methyl-3-azetidinyl)-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(6-methyl-3-pyridinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R)-2-(6-methyl-3-pyridinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S)-2-(1-(trifluoromethyl)-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2-cyclopropyl-3-methyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-3-methyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)-2-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-3-ethyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)-2-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2-methyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-3-ethyl-2-methyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-3-ethyl-2-methyl-7-((2S)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-3-ethyl-2-methyl-7-((2R
)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-3-ethyl-2-methyl-7-((2S)-2-(2-methyl-4-pyridinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(2,4-difluorophenyl)-3-ethyl-2-methyl-7-((2S)-2-(2-methyl-4-pyridinyl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
7-((2S)-2-(1-cyclopropyl-1H-pyrazol-4-yl)-4-morpholinyl)-5-(2,4-difluorophenyl)-3-ethyl-2-methylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2-methyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)-3-propylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(5-chloro-3-fluoro-2-pyridinyl)-2-methyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)-3-propylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2-methyl-7-((2S)-2-(1-methyl-1H-pyrazol-5-yl)-4-morpholinyl)-3-propylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2-methyl-7-((2R)-2-(1-methyl-1H-pyrazol-5-yl)-4-morpholinyl)-3-propylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R)-2-(difluoromethyl)-4-morpholinyl)-2-methyl-3-propylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2-methyl-7-((2S)-2-phenyl-4-morpholinyl)-3-propylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-3-methyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-cyclohexyl-2,3-dimethyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-cyclopentyl-2,3-dimethyl-7-((2S)-2-(1-methyl-1H-pyrazol-4-yl)-4-morpholinyl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R,4R)-2-(1-methyl-1H-pyrazol-4-yl)tetrahydro-2H-pyran-4-yl)pyrido[4,3-d]pyrimidin-4(3H)-one and 5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S,4S)-2-(1-methyl-1H-pyrazol-4-yl)tetrahydro-2H-pyran-4-yl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R,4S)-2-(1-methyl-1H-pyrazol-4-yl)tetrahydro-2H-pyran-4-yl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S,4R)-2-(1-methyl-1H-pyrazol-4-yl)tetrahydro-2H-pyran-4-yl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(6-(1-methyl-1H-pyrazol-4-yl)-3,6-dihydro-2H-pyran-4-yl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R,4S)-2-(1-cyclopropyl-1H-pyrazol-4-yl)tetrahydro-2H-pyran-4-yl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S,4R)-2-(1-cyclopropyl-1H-pyrazol-4-yl)tetrahydro-2H-pyran-4-yl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
(2R,4S)-4-(5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-4-oxo-3,4-dihydropyrido[4,3-d]pyrimidin-7-yl)tetrahydro-2H-pyran-2-carboxylate and (2S,4R)-4-(5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-4-oxo-3,4-dihydropyrido[4,3-d]pyrimidin-7-yl)tetrahydro-2H-pyran-2-carboxylate,
(2S,4S)-4-(5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-4-oxo-3,4-dihydropyrido[4,3-d]pyrimidin-7-yl)tetrahydro-2H-pyran-2-carboxylate and (2R,4R)-4-(5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-4-oxo-3,4-dihydropyrido[4,3-d]pyrimidin-7-yl)tetrahydro-2H-pyran-2-carboxylate,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R,4S)-2-(2-methyl-4-pyridinyl)tetrahydro-2H-pyran-4-yl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S,4R)-2-(2-methyl-4-pyridinyl)tetrahydro-2H-pyran-4-yl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-(2-(6-methylpyridin-3-yl)tetrahydro-2H-pyran-4-yl)pyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R,4S)-2-(2-methoxy-4-pyridinyl)tetrahydro-2H-pyran-4-yl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S,4R)-2-(2-methoxy-4-pyridinyl)tetrahydro-2H-pyran-4-yl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2R,4R)-2-(2-methoxy-4-pyridinyl)tetrahydro-2H-pyran-4-yl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-7-((2S,4S)-2-(2-methoxy-4-pyridinyl)tetrahydro-2H-pyran-4-yl)-2,3-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one,
5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R,4R)-2-(3-pyridinyl)tetrahydro-2H-pyran-4-yl)pyrido[4,3-d]pyrimidin-4(3H)-one and 5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S,4S)-2-(3-pyridinyl)tetrahydro-2H-pyran-4-yl)pyrido[4,3-d]pyrimidin-4(3H)-one,
2. The compound of claim 1 which is 5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2R,4S)-2-(3-pyridinyl)tetrahydro-2H-pyran-4-yl)pyrido[4,3-d]pyrimidin-4(3H)-one or 5-(4-chloro-2-fluorophenyl)-2,3-dimethyl-7-((2S,4R)-2-(3-pyridinyl)tetrahydro-2H-pyran-4-yl)pyrido[4,3-d]pyrimidin-4(3H)-one, or a tautomer thereof, or a pharma- ceutically acceptable salt of said compound or said tautomer.
または、前記化合物が、
または、前記化合物が、
または、前記化合物が、
または、前記化合物が、
または、前記化合物が、
または、前記化合物が、
または、前記化合物が、
Or, the compound is
Or, the compound is
Or, the compound is
Or, the compound is
Or, the compound is
Or, the compound is
Or, the compound is
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063019768P | 2020-05-04 | 2020-05-04 | |
US63/019,768 | 2020-05-04 | ||
PCT/US2021/030719 WO2021226135A1 (en) | 2020-05-04 | 2021-05-04 | Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2023524806A JP2023524806A (en) | 2023-06-13 |
JPWO2021226135A5 true JPWO2021226135A5 (en) | 2024-05-17 |
Family
ID=78468393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022567488A Pending JP2023524806A (en) | 2020-05-04 | 2021-05-04 | Heterocyclic compound as a trigger receptor 2 agonist expressed in myeloid cells and method of use |
Country Status (17)
Country | Link |
---|---|
US (2) | US11718617B2 (en) |
EP (1) | EP4146220A4 (en) |
JP (1) | JP2023524806A (en) |
KR (1) | KR20230020983A (en) |
CN (1) | CN116322696A (en) |
AU (1) | AU2021267161A1 (en) |
BR (1) | BR112022022338A2 (en) |
CA (1) | CA3182541A1 (en) |
CL (1) | CL2022003041A1 (en) |
CO (1) | CO2022015927A2 (en) |
CR (1) | CR20220559A (en) |
CU (1) | CU20220065A7 (en) |
EC (1) | ECSP22089520A (en) |
IL (1) | IL297845A (en) |
MX (1) | MX2022013838A (en) |
PE (1) | PE20230609A1 (en) |
WO (1) | WO2021226135A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW202334141A (en) * | 2021-11-09 | 2023-09-01 | 美商維佳神經科學有限公司 | Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use |
TW202325290A (en) * | 2021-11-09 | 2023-07-01 | 美商維佳神經科學有限公司 | Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use |
WO2024008722A2 (en) * | 2022-07-04 | 2024-01-11 | Muna Therapeutics Aps | Trem2 modulators |
Family Cites Families (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2940972A (en) | 1957-06-27 | 1960-06-14 | Thomae Gmbh Dr K | Tri-and tetra-substituted pteridine derivatives |
US2963481A (en) | 1959-11-27 | 1960-12-06 | Smith Kline French Lab | 6-pteridinecarboxylic acid esters |
JPH09510695A (en) | 1994-01-03 | 1997-10-28 | エイシア・ファーマシュウティカルズ,インコーポレイテッド | 8-Aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and their use as antagonists to the glycine / NMDA receptor |
US6331538B1 (en) | 1997-10-28 | 2001-12-18 | Warner-Lambert Company | 7-substituted quinazolin-2,4-diones useful as antibacterial agents |
EP1345603A4 (en) | 2000-12-20 | 2004-09-08 | Merck & Co Inc | (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
JP2003005355A (en) | 2001-06-20 | 2003-01-08 | Fuji Photo Film Co Ltd | Negative type resist composition for electron beam or x-ray |
WO2005007099A2 (en) | 2003-07-10 | 2005-01-27 | Imclone Systems Incorporated | Pkb inhibitors as anti-tumor agents |
ATE369862T1 (en) | 2003-10-17 | 2007-09-15 | 4 Aza Ip Nv | HETEROCYCLUS-SUBSTITUTED PTERIDINE DERIVATIVES AND THEIR USE IN THERAPY |
CA2543710A1 (en) | 2003-11-03 | 2005-05-12 | Warner-Lambert Company Llc | Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders |
JP4102939B2 (en) * | 2004-02-13 | 2008-06-18 | 萬有製薬株式会社 | Fused ring 4-oxo-pyrimidine derivatives |
BRPI0508183B8 (en) * | 2004-04-02 | 2021-05-25 | Prana Biotechnology Ltd | neurologically active compounds, their uses, pharmaceutical or veterinary composition and processes for their preparation |
US20070054916A1 (en) | 2004-10-01 | 2007-03-08 | Amgen Inc. | Aryl nitrogen-containing bicyclic compounds and methods of use |
WO2006128172A2 (en) | 2005-05-26 | 2006-11-30 | Synta Pharmaceuticals Corp. | Method for treating b cell regulated autoimmune disorders |
WO2006128129A2 (en) | 2005-05-26 | 2006-11-30 | Synta Pharmaceuticals Corp. | Method for treating cancer |
KR100659088B1 (en) | 2005-07-15 | 2006-12-21 | 삼성에스디아이 주식회사 | Difluoropyridine-based compound and organic light-emitting device employing the same |
JP2009509963A (en) | 2005-09-23 | 2009-03-12 | スミスクライン・ビーチャム・コーポレイション | New compounds |
US20090082349A1 (en) | 2006-03-02 | 2009-03-26 | Dashyant Dhanak | Thiazolones for use as pi3 kinase inhibitors |
US7855194B2 (en) | 2006-03-27 | 2010-12-21 | Hoffmann-La Roche Inc. | Pyrimidine, quinazoline, pteridine and triazine derivatives |
WO2008003149A2 (en) | 2006-07-06 | 2008-01-10 | Gilead Sciences , Inc. | Substituted pteridines for the treatment and prevention of viral infections |
US7635683B2 (en) | 2006-08-04 | 2009-12-22 | Enanta Pharmaceuticals, Inc. | Quinoxalinyl tripeptide hepatitis C virus inhibitors |
RS55881B1 (en) | 2006-08-23 | 2017-08-31 | Kudos Pharm Ltd | 2-methylmorpholine pyrido-,pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors |
US8048894B2 (en) | 2007-04-18 | 2011-11-01 | Amgen Inc. | Quinolones and azaquinolones that inhibit prolyl hydroxylase |
KR20100089082A (en) | 2007-10-15 | 2010-08-11 | 아스트라제네카 아베 | Combination 059 |
US20110098267A1 (en) | 2008-02-07 | 2011-04-28 | Synta Pharmaceuticals Corporation | Topical formulations for the treatment of psoriasis |
US8298825B1 (en) | 2008-08-25 | 2012-10-30 | The General Hospital Corporation | TGF-beta receptor inhibitors to enhance direct reprogramming |
US20120021519A1 (en) | 2008-09-19 | 2012-01-26 | Presidents And Fellows Of Harvard College | Efficient induction of pluripotent stem cells using small molecule compounds |
PT3135672T (en) | 2008-10-10 | 2020-04-02 | Vm Discovery Inc | Compositions and methods for treating alcohol use disorders, pain and other diseases |
AR076126A1 (en) | 2009-03-18 | 2011-05-18 | Schering Corp | BICYCLE COMPOUNDS AS INHIBITORS OF DIACILGLICEROL ACILTRANSFERASA |
US8691187B2 (en) | 2009-03-23 | 2014-04-08 | Eli Lilly And Company | Imaging agents for detecting neurological disorders |
WO2011014039A1 (en) | 2009-07-31 | 2011-02-03 | Rohm And Haas Electronic Materials Korea Ltd. | Novel organic electroluminescent compounds and organic electroluminescent device using the same |
US20110124597A1 (en) | 2009-09-25 | 2011-05-26 | Anacor Pharmaceuticals, Inc. | Boron containing small molecules |
CA2793299A1 (en) | 2010-03-16 | 2011-09-22 | Merck Patent Gmbh | Morpholinylquinazolines |
US9139592B2 (en) | 2010-06-14 | 2015-09-22 | Trt Pharma Inc. | Modulators of Nrf2 and uses thereof |
CN102887895B (en) | 2011-07-22 | 2016-08-24 | 山东轩竹医药科技有限公司 | Pyridopyrimidine class mTOR inhibitors |
KR101497124B1 (en) | 2011-11-28 | 2015-03-06 | 덕산네오룩스 주식회사 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof |
IN2014MN01736A (en) | 2012-02-08 | 2015-07-10 | Janssen R & D Ireland | |
CN103374021B (en) | 2012-04-21 | 2015-10-28 | 通化济达医药有限公司 | Pyridopyrimidine class HDAC containing zinc binding moiety and mTOR inhibitors |
WO2014146249A1 (en) | 2013-03-19 | 2014-09-25 | Merck Sharp & Dohme Corp. | Geminally substituted cyanoethylpyrazolo pyridones as janus kinase inhibitors |
JP6192836B2 (en) | 2013-07-30 | 2017-09-06 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Azaindole compounds as RORC modulators |
CN105814022B (en) | 2013-12-09 | 2018-09-28 | Ucb生物制药私人有限公司 | Condensed bicyclic heteroaromatic derivative as TNF active regulators |
KR20150080966A (en) | 2014-01-02 | 2015-07-13 | 최돈수 | Light-emitting material for organic electroluminescent device, organic electroluminescent device using same, and material for organic electroluminescent device |
KR20160060572A (en) | 2014-11-19 | 2016-05-30 | 주식회사 엠비케이 | Organic electroluminescent compound, ink composition, organic electroluminescent device and electric apparatus |
US10403826B2 (en) | 2015-05-07 | 2019-09-03 | Universal Display Corporation | Organic electroluminescent materials and devices |
JP6805235B2 (en) | 2015-08-11 | 2020-12-23 | メルク パテント ゲーエムベーハー | Materials for OLED devices |
WO2017031427A1 (en) | 2015-08-19 | 2017-02-23 | 3-V Biosciences, Inc. | COMPOUNDS AND METHODS FOR INHIBITING mTOR |
KR102606277B1 (en) | 2016-04-06 | 2023-11-27 | 삼성디스플레이 주식회사 | Organic light emitting device |
US10573692B2 (en) | 2016-04-06 | 2020-02-25 | Samsung Display Co., Ltd. | Organic light-emitting device having a sealing thin film encapsulation portion |
CA3021062A1 (en) | 2016-04-15 | 2017-10-19 | Epizyme, Inc. | Amine-substituted aryl or heteroaryl compounds as ehmt1 and ehmt2 inhibitors |
WO2018067704A1 (en) | 2016-10-04 | 2018-04-12 | Enanta Pharmaceuticals, Inc. | Isoxazole analogs as fxr agonists and methods of use thereof |
US11283028B2 (en) | 2016-10-05 | 2022-03-22 | Rohm And Haas Electronic Materials Korea Ltd. | Organic electroluminescent compound and organic electroluminescent device comprising the same |
WO2018108110A1 (en) | 2016-12-13 | 2018-06-21 | 广州华睿光电材料有限公司 | Metal organic complex and use thereof, mixture, and organic electronic device |
TW201843143A (en) | 2017-03-13 | 2018-12-16 | 德商麥克專利有限公司 | Compounds containing arylamine structures |
WO2018169352A1 (en) | 2017-03-16 | 2018-09-20 | Rohm And Haas Electronic Materials Korea Ltd. | Organic electroluminescent device |
KR102335935B1 (en) | 2017-03-22 | 2021-12-06 | 덕산네오룩스 주식회사 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof |
WO2018183923A1 (en) | 2017-03-31 | 2018-10-04 | Epizyme, Inc. | Methods of using ehmt2 inhibitors |
KR102389204B1 (en) | 2017-04-18 | 2022-04-21 | 덕산네오룩스 주식회사 | Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof |
WO2018195450A1 (en) | 2017-04-21 | 2018-10-25 | Epizyme, Inc. | Combination therapies with ehmt2 inhibitors |
WO2018204765A1 (en) | 2017-05-05 | 2018-11-08 | Pairnomix, Llc | Methods of treating epilepsy and kcnq2 related conditions |
JP2020523389A (en) | 2017-06-13 | 2020-08-06 | コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼーション | Antiviral drug |
WO2019065516A1 (en) | 2017-09-26 | 2019-04-04 | 日本曹達株式会社 | Quinoline compound, and bactericidal agent for agricultural and horticultural use |
IL310625A (en) | 2017-10-18 | 2024-04-01 | Epizyme Inc | Methods of using ehmt2 inhibitors in treating or preventing blood disorders |
CA3079412A1 (en) | 2017-10-18 | 2019-04-25 | Epizyme, Inc. | Methods of using ehmt2 inhibitors in immunotherapies |
CN108484680B (en) | 2018-01-31 | 2020-12-11 | 马鞍山南京大学高新技术研究院 | Iridium complex with bis-thio aromatic ring/aromatic heterocyclic phosphoric acid compound as auxiliary ligand |
US11090304B2 (en) | 2018-05-04 | 2021-08-17 | Amgen Inc. | KRAS G12C inhibitors and methods of using the same |
US20200075870A1 (en) | 2018-08-22 | 2020-03-05 | Universal Display Corporation | Organic electroluminescent materials and devices |
CN109265457A (en) | 2018-11-01 | 2019-01-25 | 中国药科大学 | A kind of new method using oxidation aromatisation building pyridopyrimidine dione skeleton |
WO2020231739A2 (en) | 2019-05-10 | 2020-11-19 | Antidote Ip Holdings, Llc | Compounds and methods for treating cancer |
CN110283171A (en) | 2019-07-17 | 2019-09-27 | 鼎泰(南京)临床医学研究有限公司 | Compound of the one kind containing Pyridopyrimidine -4- amine structure, pharmaceutical composition and its application |
US11820783B2 (en) | 2019-09-06 | 2023-11-21 | Universal Display Corporation | Organic electroluminescent materials and devices |
TW202208355A (en) | 2020-05-04 | 2022-03-01 | 美商安進公司 | Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use |
CN111454265B (en) | 2020-05-07 | 2021-08-24 | 宁波卢米蓝新材料有限公司 | Fused heterocyclic compound and preparation method and application thereof |
-
2021
- 2021-05-04 CN CN202180045770.6A patent/CN116322696A/en active Pending
- 2021-05-04 BR BR112022022338A patent/BR112022022338A2/en unknown
- 2021-05-04 CR CR20220559A patent/CR20220559A/en unknown
- 2021-05-04 IL IL297845A patent/IL297845A/en unknown
- 2021-05-04 JP JP2022567488A patent/JP2023524806A/en active Pending
- 2021-05-04 WO PCT/US2021/030719 patent/WO2021226135A1/en active Application Filing
- 2021-05-04 EP EP21799590.1A patent/EP4146220A4/en active Pending
- 2021-05-04 MX MX2022013838A patent/MX2022013838A/en unknown
- 2021-05-04 CU CU2022000065A patent/CU20220065A7/en unknown
- 2021-05-04 CA CA3182541A patent/CA3182541A1/en active Pending
- 2021-05-04 AU AU2021267161A patent/AU2021267161A1/en active Pending
- 2021-05-04 KR KR1020227042514A patent/KR20230020983A/en active Search and Examination
- 2021-05-04 PE PE2022002572A patent/PE20230609A1/en unknown
-
2022
- 2022-11-03 CL CL2022003041A patent/CL2022003041A1/en unknown
- 2022-11-04 CO CONC2022/0015927A patent/CO2022015927A2/en unknown
- 2022-11-21 EC ECSENADI202289520A patent/ECSP22089520A/en unknown
- 2022-11-30 US US18/072,497 patent/US11718617B2/en active Active
-
2023
- 2023-04-28 US US18/309,281 patent/US20240124446A1/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7001682B2 (en) | Substitution 1H-imidazole [4,5-b] pyridin-2 (3H) -one and their use as GLUN2B receptor regulators | |
RU2473549C2 (en) | Pyrimidine compounds, compositions and methods of use | |
US9611278B2 (en) | Soluble guanylate cyclase activators | |
HRP20191327T1 (en) | 4-hydroxy-3-(heteroaryl)pyridine-2-one apj agonists for use in the treatment of cardiovascular disorders | |
JP2017523223A5 (en) | ||
JP2021502356A5 (en) | ||
RU2014152625A (en) | Azadecaline Condensed with Heteroaryl Ketones - Modulators of Glucocorticoid Receptors | |
HRP20201746T1 (en) | Aromatic sulfonamide derivatives | |
HRP20211957T1 (en) | 1,4-disubstituted pyridazine analogs and methods for treating smn-deficiency-related conditions | |
AU2012299080B2 (en) | Pyrimidine PDE10 inhibitors | |
JP2018522859A5 (en) | ||
JP2015517580A5 (en) | ||
JP2013523884A5 (en) | ||
JP2016523911A5 (en) | ||
JP2017500364A5 (en) | ||
EP3209664B1 (en) | Bicyclic heteroaryl amine compounds as pi3k inhibitors | |
EA023254B1 (en) | Soluble guanylate cyclase activators | |
JP2015522002A5 (en) | ||
JP2011509937A5 (en) | ||
HRP20180371T1 (en) | Novel pyridine derivatives | |
RU2018113430A (en) | Derivatives of L-Phenylpyrrolidin-2-OH as PERK INHIBITORS | |
TW201619154A (en) | Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use | |
JP2020526549A5 (en) | ||
KR20220027196A (en) | Imidazo[1,2-a]pyridinyl derivatives and their use in the treatment of diseases | |
JP2013518823A5 (en) |